<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id>
      <journal-id journal-id-type="publisher-id">vaccines</journal-id>
      <journal-title-group>
        <journal-title>Vaccines</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2076-393X</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36992237</article-id>
      <article-id pub-id-type="pmc">10054502</article-id>
      <article-id pub-id-type="doi">10.3390/vaccines11030654</article-id>
      <article-id pub-id-type="publisher-id">vaccines-11-00654</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7726-9532</contrib-id>
          <name>
            <surname>Elbehiry</surname>
            <given-names>Ayman</given-names>
          </name>
          <xref rid="af1-vaccines-11-00654" ref-type="aff">1</xref>
          <xref rid="af2-vaccines-11-00654" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aldubaib</surname>
            <given-names>Musaad</given-names>
          </name>
          <xref rid="af3-vaccines-11-00654" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1699-6263</contrib-id>
          <name>
            <surname>Marzouk</surname>
            <given-names>Eman</given-names>
          </name>
          <xref rid="af1-vaccines-11-00654" ref-type="aff">1</xref>
          <xref rid="c1-vaccines-11-00654" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2294-9837</contrib-id>
          <name>
            <surname>Abalkhail</surname>
            <given-names>Adil</given-names>
          </name>
          <xref rid="af1-vaccines-11-00654" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9997-7476</contrib-id>
          <name>
            <surname>Almuzaini</surname>
            <given-names>Abdulaziz M.</given-names>
          </name>
          <xref rid="af3-vaccines-11-00654" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0864-5260</contrib-id>
          <name>
            <surname>Rawway</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref rid="af4-vaccines-11-00654" ref-type="aff">4</xref>
          <xref rid="af5-vaccines-11-00654" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alghamdi</surname>
            <given-names>Ali</given-names>
          </name>
          <xref rid="af6-vaccines-11-00654" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alqarni</surname>
            <given-names>Abdullah</given-names>
          </name>
          <xref rid="af7-vaccines-11-00654" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aldawsari</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref rid="af8-vaccines-11-00654" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4412-3515</contrib-id>
          <name>
            <surname>Draz</surname>
            <given-names>Abdelmaged</given-names>
          </name>
          <xref rid="af3-vaccines-11-00654" ref-type="aff">3</xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Banai</surname>
            <given-names>Menachem</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-vaccines-11-00654"><label>1</label>Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi Arabia</aff>
      <aff id="af2-vaccines-11-00654"><label>2</label>Department of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32511, Egypt</aff>
      <aff id="af3-vaccines-11-00654"><label>3</label>Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi Arabia</aff>
      <aff id="af4-vaccines-11-00654"><label>4</label>Biology Department, College of Science, Jouf University, Sakaka 42421, Saudi Arabia</aff>
      <aff id="af5-vaccines-11-00654"><label>5</label>Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt</aff>
      <aff id="af6-vaccines-11-00654"><label>6</label>Department of Optometry, King Fahad Armed Hospital, Jeddah 23311, Saudi Arabia</aff>
      <aff id="af7-vaccines-11-00654"><label>7</label>Department of Family Medicine, King Fahad Armed Hospital, Jeddah 23311, Saudi Arabia</aff>
      <aff id="af8-vaccines-11-00654"><label>8</label>Department of Medical services, Ministry of Defense, Riyadh 12426, Saudi Arabia</aff>
      <author-notes>
        <corresp id="c1-vaccines-11-00654"><label>*</label>Correspondence: <email>e.marzouk@qu.edu.sa</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>3</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2023</year>
      </pub-date>
      <volume>11</volume>
      <issue>3</issue>
      <elocation-id>654</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>12</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>06</day>
          <month>3</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2023 by the authors.</copyright-statement>
        <copyright-year>2023</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Brucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-specific manner, making laboratory confirmation of the diagnosis critical to the patient&#x2019;s recovery. A coordinated strategy for diagnosing and controlling brucellosis throughout the Middle East is required, as this disease cannot be known to occur without reliable microbiological, molecular, and epidemiological evidence. Consequently, the current review focuses on the current and emerging microbiological diagnostic tools for the early detection and control of human brucellosis. Laboratory assays such as culturing, serology, and molecular analysis can frequently be used to diagnose brucellosis. Although serological markers and nucleic acid amplification techniques are extremely sensitive, and extensive experience has been gained with these techniques in the laboratory diagnosis of brucellosis, a culture is still considered to be the &#x201C;gold standard&#x201D; due to the importance of this aspect of public health and clinical care. In endemic regions, however, serological tests remain the primary method of diagnosis due to their low cost, user-friendliness, and strong ability to provide a negative prediction, so they are commonly used. A nucleic acid amplification assay, which is highly sensitive, specific, and safe, is capable of enabling rapid disease diagnosis. Patients who have reportedly fully healed may continue to have positive molecular test results for a long time. Therefore, cultures and serological methods will continue to be the main tools for diagnosing and following up on human brucellosis for as long as no commercial tests or studies demonstrate adequate interlaboratory reproducibility. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Over the past few decades, several studies have been conducted to develop <italic toggle="yes">Brucella</italic> vaccines, but the problem of controlling brucellosis in both humans and animals remains challenging. Therefore, this review also aims to present an updated overview of the different types of brucellosis vaccines that are currently available.</p>
      </abstract>
      <kwd-group>
        <kwd>zoonotic brucellosis</kwd>
        <kwd>history</kwd>
        <kwd>diagnostic approaches</kwd>
        <kwd>vaccine development</kwd>
        <kwd>public health</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Deputyship for Research &amp; Innovation, Ministry of Education, Saudi Arabia</funding-source>
          <award-id>QU-IF-5-2-4-33856</award-id>
        </award-group>
        <funding-statement>This research was funded by Deputyship for Research &amp; Innovation, Ministry of Education, Saudi Arabia, grant number QU-IF-5-2-4-33856.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-vaccines-11-00654">
      <title>1. Introduction</title>
      <p>Zoonotic brucellosis causes multi-systemic disease in humans and animals throughout the world; thus, the link between animal reproduction and human cases causes significant financial losses in many human living systems [<xref rid="B1-vaccines-11-00654" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-11-00654" ref-type="bibr">2</xref>,<xref rid="B3-vaccines-11-00654" ref-type="bibr">3</xref>]. Each year, it is estimated that there are approximately 500,000 new cases of humans infected with brucellosis [<xref rid="B4-vaccines-11-00654" ref-type="bibr">4</xref>,<xref rid="B5-vaccines-11-00654" ref-type="bibr">5</xref>,<xref rid="B6-vaccines-11-00654" ref-type="bibr">6</xref>]. Among the cases recorded, the majority of cases occur in the Mideast, Central Asia, Adriatic nations, India, Central and South America, and Mexico [<xref rid="B7-vaccines-11-00654" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-11-00654" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-11-00654" ref-type="bibr">9</xref>]. Some countries do not have comprehensive case records or the infrastructure to report fevers of uncertain origin [<xref rid="B5-vaccines-11-00654" ref-type="bibr">5</xref>].</p>
      <p>David Bruce discovered an organism called &#x201C;<italic toggle="yes">Micrococcus melitensis</italic>&#x201D; from autopsy samples taken from the spleens, livers, and kidneys of infected British soldiers in Malta. The organism was first identified by him as the cause of brucellosis, which was later renamed &#x201C;<italic toggle="yes">Brucella melitensis</italic>&#x201D; in his honor by Meyer and Shaw [<xref rid="B10-vaccines-11-00654" ref-type="bibr">10</xref>]. Hence, it is commonly known as brucellosis illness. Wildlife and farmed animals such as cattle, sheep, goats, camels, and pigs are affected [<xref rid="B11-vaccines-11-00654" ref-type="bibr">11</xref>]. It is also referred to as Bang&#x2019;s disease, enzootic abortion, and contagious abortion in animals [<xref rid="B12-vaccines-11-00654" ref-type="bibr">12</xref>]. Other names include Malta fever, Mediterranean fever, intermittent fever, and undulant fever in humans. Professional techniques, including herd management, have established a risk group, but the disease is widely transmitted into the public due to consumption of infected milk and dairy products. Both breeders and the common public noticed a cluster of phenomena following the spread of the disease. There is significant diversity of zoonoses around the world, but the World Health Organization (WHO) has selected this disease as one of the most serious &#x201C;ignored zoonoses&#x201D; in the world, since it has an especially substantial impact on poverty-stricken nations [<xref rid="B13-vaccines-11-00654" ref-type="bibr">13</xref>]. <italic toggle="yes">Brucella</italic> has been designated as a hazard group III pathogen by the WHO due to its ease of aerosol transmission [<xref rid="B14-vaccines-11-00654" ref-type="bibr">14</xref>].</p>
      <p><italic toggle="yes">Brucella</italic> is a genus of Gram-negative bacteria [<xref rid="B15-vaccines-11-00654" ref-type="bibr">15</xref>,<xref rid="B16-vaccines-11-00654" ref-type="bibr">16</xref>] commonly referred to as coccobacilli, and is characterized by being small, non-capsulated, non-motile [<xref rid="B17-vaccines-11-00654" ref-type="bibr">17</xref>], and intracellular. Classical &#x201C;core&#x201D; <italic toggle="yes">Brucella</italic> species that can cause disease in humans include <italic toggle="yes">Brucella abortus</italic> (<italic toggle="yes">B. abortus</italic>), <italic toggle="yes">Brucella melitensis</italic> (<italic toggle="yes">B. melitensis</italic>), <italic toggle="yes">Brucella suis</italic> (<italic toggle="yes">B. suis</italic>) biovars 1 and 3, and, to a lesser extent, <italic toggle="yes">Brucella canis</italic> (<italic toggle="yes">B. canis</italic>), all of which are pathogenic. A number of new <italic toggle="yes">Brucella</italic> species have recently been reported in foreign frogs, and are genetically very variable in comparison to recognized classical <italic toggle="yes">Brucella</italic> species [<xref rid="B18-vaccines-11-00654" ref-type="bibr">18</xref>]. In 2009, Scholz and his colleagues, through the work they were conducting in Lower Austria, <italic toggle="yes">Brucella microti</italic> (<italic toggle="yes">B. microti</italic>) was isolated from the mandibular lymph nodes of a red fox and validly published as a new species based upon molecular analysis. It has also been demonstrated that <italic toggle="yes">Brucella ceti</italic> (<italic toggle="yes">B. ceti</italic>) was isolated from wildlife dolphins living in the Pacific Ocean and the Mediterranean Sea [<xref rid="B19-vaccines-11-00654" ref-type="bibr">19</xref>]. This shows that <italic toggle="yes">B. ceti</italic> is prevalent in marine environments and suggests that it has the potential to spread through aquatic animals, including dolphins, as well as other species. Furthermore, a previous report of a severe central nervous system infection caused by a marine mammal <italic toggle="yes">Brucella</italic> strain also supports the possibility that these microorganisms can spread from their original hosts and become infectious in people who live in a communal setting [<xref rid="B20-vaccines-11-00654" ref-type="bibr">20</xref>]. It was only recently discovered that a new species, known as <italic toggle="yes">B. pseudogrignonensis,</italic> was found in the blood sample of a man [<xref rid="B21-vaccines-11-00654" ref-type="bibr">21</xref>]. There is also a close relationship between atypical <italic toggle="yes">Brucella</italic> and core <italic toggle="yes">Brucella</italic>, which can be found in a similar ecosystem. According to Leclercq et al. [<xref rid="B22-vaccines-11-00654" ref-type="bibr">22</xref>] and Ryan and Pembroke [<xref rid="B23-vaccines-11-00654" ref-type="bibr">23</xref>], <italic toggle="yes">Brucella</italic> is one of several species within <italic toggle="yes">Ochrobactrum</italic>, but its exact place in the genus <italic toggle="yes">Ochrobactrum</italic> is still in question.</p>
      <p>The prevalence of brucellosis in livestock, especially in low- and middle-income countries, has significant socioeconomic consequences [<xref rid="B13-vaccines-11-00654" ref-type="bibr">13</xref>,<xref rid="B24-vaccines-11-00654" ref-type="bibr">24</xref>,<xref rid="B25-vaccines-11-00654" ref-type="bibr">25</xref>]. Among the primary consequences of this disease are infertility, fetal death, late-gestation abortion, and decreased cattle productivity [<xref rid="B26-vaccines-11-00654" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-11-00654" ref-type="bibr">27</xref>]. It is becoming more and more evident that brucellosis poses a serious public health risk in many underdeveloped countries due to the rise in incidences of morbidity in both humans and animals [<xref rid="B28-vaccines-11-00654" ref-type="bibr">28</xref>,<xref rid="B29-vaccines-11-00654" ref-type="bibr">29</xref>]. It is possible for humans to become infected with the disease either by coming into direct contact with sick animals or by consuming contaminated milk and milk products [<xref rid="B29-vaccines-11-00654" ref-type="bibr">29</xref>]. Brucellosis can also cause flu-like symptoms in humans (i.e., malaria, typhoid, streptococcal infections, and rheumatoid arthritis). Clinically, it cannot be distinguished from other influenza-like diseases, except rheumatoid arthritis [<xref rid="B30-vaccines-11-00654" ref-type="bibr">30</xref>]. As a result, physicians have encountered difficulties when dealing with acute human brucellosis [<xref rid="B31-vaccines-11-00654" ref-type="bibr">31</xref>].</p>
      <p>In the diagnosis of human brucellosis, the microbiology laboratory plays an important role. Because human clinical symptoms are inconsistent and vague, it is very difficult to devise a proper therapy for these cases without using the microbiology laboratory [<xref rid="B32-vaccines-11-00654" ref-type="bibr">32</xref>]. In order to be able to correctly diagnose, there are three principles and methods that can be used in the laboratory: direct diagnosis through culture, indirect diagnosis through serological tests, and quick diagnosis utilizing PCR-based techniques. Among the many methods that are used to diagnose <italic toggle="yes">Brucella</italic>, clinical examination, bacterial culture from various biological sources, microscopy, biochemical tests, and serology are all parts of the standard diagnosis systems (such as the Rose Bengal test, latex agglutination test, complement fixation test, and enzyme-linked immunosorbent assay) [<xref rid="B33-vaccines-11-00654" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-11-00654" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-11-00654" ref-type="bibr">35</xref>]. It is important to note that these procedures require extensive time and resources to be performed, and some have limited sensitivity and/or specificity or require employees to have laboratory training and a biosafety level 3 facility [<xref rid="B36-vaccines-11-00654" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-11-00654" ref-type="bibr">37</xref>]. In order to manage livestock brucellosis, there is no need to prescribe medication, since all animal species that test positive for the disease must be slaughtered [<xref rid="B6-vaccines-11-00654" ref-type="bibr">6</xref>,<xref rid="B38-vaccines-11-00654" ref-type="bibr">38</xref>]. Nevertheless, a latency may persist and hamper immediate success in disease eradication. </p>
      <p>The primary risk factors for occupational brucellosis include close contact with animal feces, veterinary services, and laboratories. These activities increase the chance of transmission through inhalation, ingestion, or direct contact with infected animals, animal products, or contaminated surfaces. People who work in these environments are at a higher risk for occupational brucellosis [<xref rid="B39-vaccines-11-00654" ref-type="bibr">39</xref>]. Handling potentially infectious animals, contaminated biological supplies, and live attenuated anti-brucellosis vaccines are all examples of risk factors for human brucellosis; however, more detailed knowledge regarding the specific risk factors for each occupation as well as how these risks can be measured remains to be elucidated [<xref rid="B40-vaccines-11-00654" ref-type="bibr">40</xref>]. To prevent the spread of brucellosis among professions that directly handle animals or animal products, effective preventive measures, such as the use of personal protective equipment, are necessary [<xref rid="B40-vaccines-11-00654" ref-type="bibr">40</xref>]. For more effective preventative measures to reduce the burden of the disease in groups exposed to their work activities, more precise data regarding the epidemiology of job-related brucellosis are necessary [<xref rid="B40-vaccines-11-00654" ref-type="bibr">40</xref>]. Knowing which industries and occupations are more likely to be exposed to brucellosis, as well as the factors that might increase their risk, would help to inform better prevention strategies, such as better hygiene practices, vaccination programs, and improved working conditions [<xref rid="B9-vaccines-11-00654" ref-type="bibr">9</xref>]. There are currently approximately 3.5 billion people in the world who are at risk of contracting brucellosis. This disease has serious consequences for the general population and results in significant economic loss as a result of therapy and reduced productivity, which leads to substantial economic losses [<xref rid="B41-vaccines-11-00654" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-11-00654" ref-type="bibr">42</xref>]. </p>
      <p>The aims of brucellosis treatment, as summarized by Al Dahouk and N&#xF6;ckler [<xref rid="B43-vaccines-11-00654" ref-type="bibr">43</xref>] and Doganay and Aygen [<xref rid="B44-vaccines-11-00654" ref-type="bibr">44</xref>], are to reduce or eliminate the symptoms, minimize complications, and prevent recurrences of the infection. By treating brucellosis rapidly, efficiently, and with early antibiotics, effective eradication with successful curing will be achieved. Several <italic toggle="yes">Brucella</italic> outbreaks have been reported in animal populations in the past few years. Despite early interventions to prevent the disease from spreading, human cases have relapsed [<xref rid="B45-vaccines-11-00654" ref-type="bibr">45</xref>]. The cause for these exacerbations is still being investigated, but it is unclear whether they were caused by the emergence of acquired resistance or whether they were caused by confinement within affected regions&#x2014;for example, the parenchymatous organs and bones [<xref rid="B6-vaccines-11-00654" ref-type="bibr">6</xref>]. Although numerous research efforts have been made to determine how to eradicate brucellosis infection globally, the intermittent nature of brucellosis is still a serious concern and remains unclear to researchers [<xref rid="B46-vaccines-11-00654" ref-type="bibr">46</xref>]. Since the beginning of the twentieth century, there have been a number of inquiries and research projects that have been devoted to developing brucellosis vaccines. The production of vaccines against brucellosis has involved the use of inactivated, live-attenuated, and rough-attenuated vaccines [<xref rid="B47-vaccines-11-00654" ref-type="bibr">47</xref>]. <italic toggle="yes">Brucella</italic> vaccines play an important role in the prophylactic control of the disease. However, from both historical and contemporary perspectives, these vaccines do not provide an ultimate solution, as development of a national policy is required first, and enforcement later. Novel vaccines have not been yet employed, but their goals are to overcome adverse results such as the existence of zoonotic strains, to differentiate infected from vaccinated animals (DIVA), and to cause abortions similarly to wild strains; therefore, a simple approach is insufficient.</p>
    </sec>
    <sec id="sec2-vaccines-11-00654">
      <title>2. An Overview of Brucellosis&#x2019; History and Current Status</title>
      <p>The first time that brucellosis was named a &#x201C;Mediterranean relapsing gastric fever&#x201D; was in 1861, when surgical assistant Jeffery Allen Marston, based in Malta, presented a case of the disease at the Royal Academy of Medicine in the United Kingdom [<xref rid="B48-vaccines-11-00654" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-11-00654" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-11-00654" ref-type="bibr">50</xref>]. During a survey of malnourished British soldiers living in Malta in 1887, David Bruce discovered a microorganism he named <italic toggle="yes">Micrococcus melitensis</italic>. This is a Gram-negative organism that can reach a length of 3 &#x3BC;m, and it can be found alone or in pairs in different environments [<xref rid="B51-vaccines-11-00654" ref-type="bibr">51</xref>]. There was a report published in 1895 by Bernard Lauritz Frederik Bang stating that <italic toggle="yes">Bacillus abortus</italic> had been isolated from the fetus, placenta, and uterine secretions of cattle during infectious abortions in four different places [<xref rid="B50-vaccines-11-00654" ref-type="bibr">50</xref>,<xref rid="B52-vaccines-11-00654" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-11-00654" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-11-00654" ref-type="bibr">54</xref>]. Wright and Smith established, in 1897, that brucellosis is a zoonotic disease through serum agglutination assays after they discovered antibodies specific to <italic toggle="yes">B. melitensis</italic> in human and animal serum [<xref rid="B50-vaccines-11-00654" ref-type="bibr">50</xref>,<xref rid="B55-vaccines-11-00654" ref-type="bibr">55</xref>]. Maltese citizen Themistocles Zammit, together with a large number of scientific members of the Mediterranean fever commission led by Bruce, established that goat&#x2019;s milk was one of the reservoirs of the organism causing this disease, and the goats were exterminated in November 1906 [<xref rid="B56-vaccines-11-00654" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-11-00654" ref-type="bibr">57</xref>]. </p>
      <p>The prevalence of brucellosis varies from country to country, but the countries located in the Mediterranean region are the most likely to be affected by this disease. In countries with low incomes, this illness is associated with a high morbidity rate. There have been several industrialized nations that have successfully eliminated this disease from their livestock [<xref rid="B50-vaccines-11-00654" ref-type="bibr">50</xref>,<xref rid="B57-vaccines-11-00654" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-11-00654" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-11-00654" ref-type="bibr">59</xref>]. From the middle of the 1980s until the beginning of the 1990s, the growth of human disease in North African countries (in particular, Morocco and Algeria) suggested the termination of this epidemiological rush. Furthermore, the illness received increased attention after a major epidemic struck Gharda&#xEF;a in 1984, with 600 cases identified. Later, the disease was found in several states across several countries, including the cities of Tlemcen (1986) and S&#xE9;tif (1989) in northwestern Algeria. This infection was thought to be caused primarily by the consumption of cheese, as mentioned by Benhabyles et al. [<xref rid="B60-vaccines-11-00654" ref-type="bibr">60</xref>]. There was an increase of approximately 12% in bovine brucellosis infection rates in Algeria between 1969 and 1976 as a result of serological identification of the disease [<xref rid="B61-vaccines-11-00654" ref-type="bibr">61</xref>]. The overall seropositivity in sheep and goats between 1986 and 1989 was 2.12%, compared to 12.0% in 1985&#x2013;1988. In the same study, 43.5% and 42% of sheep and goat flocks were affected, respectively [<xref rid="B62-vaccines-11-00654" ref-type="bibr">62</xref>]. </p>
    </sec>
    <sec id="sec3-vaccines-11-00654">
      <title>3. Prevalence of Human Brucellosis</title>
      <p>The prevalence of human brucellosis remains a global public health challenge due to its major health implications (such as infertility and pregnancy losses) and economic impact, particularly in areas with frequent animal infections [<xref rid="B62-vaccines-11-00654" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-11-00654" ref-type="bibr">63</xref>]. Occasionally, <italic toggle="yes">Brucella</italic> infection can cause disease in newborns [<xref rid="B64-vaccines-11-00654" ref-type="bibr">64</xref>]. In certain circumstances, breast milk may be considered a potential mode of transmission for <italic toggle="yes">B. melitensis</italic> biovar 1 [<xref rid="B65-vaccines-11-00654" ref-type="bibr">65</xref>]. The prevalence of brucellosis in humans is determined by the type of domestic host, species of infected herds, and their density, as documented by over 1000 articles published by the WHO over the past 70 years (accessed on 1 December 2021 at <uri xlink:href="https://www.who.int">https://www.who.int</uri>), with many of them describing the prevalence of the disease worldwide [<xref rid="B29-vaccines-11-00654" ref-type="bibr">29</xref>]. Among Middle Eastern nations recently reported to have brucellosis are Syria, Yemen, Saudi Arabia, Turkey, and Iran [<xref rid="B8-vaccines-11-00654" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-11-00654" ref-type="bibr">9</xref>]. Moreover, it remains an epidemic in both Africa and Asia [<xref rid="B66-vaccines-11-00654" ref-type="bibr">66</xref>]. In areas with limited access to healthcare and diagnostic services, brucellosis prevalence is often not reported due to the lack of passive reports from hospitals and diagnostic labs. Several high-income nations, however, have documented a low prevalence of human brucellosis as compared to places where it is prevalent. In 2017, 381 cases of brucellosis were confirmed in 28 European countries, representing a rate of 0.09 for every 100,000 people per year [<xref rid="B67-vaccines-11-00654" ref-type="bibr">67</xref>]. The WHO reported that 67.2% of confirmed cases were reported in Greece, Italy, and Spain, with Greece having the highest rate of occurrence. </p>
      <p>In 2015, a randomized trial carried out in Costa Rica&#x2019;s Huetar Norte Region (170 inhabitants) found human brucellosis prevalence at 12.5% among rural at-risk people. A Ministry of Health report confirmed that 144 human brucellosis cases had been reported for the entire country (at the time having 4.5 million inhabitants) but there had been only eight reported for the same northern region [<xref rid="B68-vaccines-11-00654" ref-type="bibr">68</xref>]. Additionally, inconsistent numbers have also been found in Colombia and Mexico [<xref rid="B69-vaccines-11-00654" ref-type="bibr">69</xref>,<xref rid="B70-vaccines-11-00654" ref-type="bibr">70</xref>], as well as other countries [<xref rid="B71-vaccines-11-00654" ref-type="bibr">71</xref>] that provide a similar picture. China has seen dramatic changes in human brucellosis over the past seven decades, particularly in the 1980s, when socioeconomic development grew significantly [<xref rid="B72-vaccines-11-00654" ref-type="bibr">72</xref>,<xref rid="B73-vaccines-11-00654" ref-type="bibr">73</xref>]. The National Brucellosis Prevention and Control Plan was implemented in China from 2016 to 2020 to eradicate the disease in both animals and humans [<xref rid="B74-vaccines-11-00654" ref-type="bibr">74</xref>]. A single dose providing lifetime protection is a recommended approach; however, different policies such repeated vaccination are still being employed in endemic areas.</p>
      <p>The erroneous results may also be the outcome of a lack of instruments within a particular field, such as diagnostic tests and long-term epidemiological interventions. Alternatively, there are situations where there are some misunderstandings about how to attain relevant numbers, how the various tests function in certain epidemiological conditions, and the strategies for acquiring them. In other cases, there may be inadequate knowledge regarding how relevant data are produced and how the numerous tests perform in various epidemiological situations. Throughout the years, the &#x201C;500,000 cases of brucellosis&#x201D; figure, as well as the &#x201C;percentage of undercounted cases&#x201D; figure, has been repeated in many publications in the form of sentences such as: &#x201C;There are about half a million cases of brucellosis reported worldwide every year. However, because of the disease&#x2019;s imprecise clinical manifestations, there is a possibility that this number could be 10 times greater.&#x201D; [<xref rid="B75-vaccines-11-00654" ref-type="bibr">75</xref>].</p>
    </sec>
    <sec id="sec4-vaccines-11-00654">
      <title>4. Diagnostic Approaches of Zoonotic Brucellosis</title>
      <p>A misdiagnosis of brucellosis may lead to unfavorable medication effects as well as missing more serious infections or non-infectious diseases that require immediate hospitalization [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. An important factor that complicates <italic toggle="yes">Brucella</italic> infections is that they typically require continuous treatment with combinations of antibiotics that are generally not advised in the treatment of other contagious diseases [<xref rid="B77-vaccines-11-00654" ref-type="bibr">77</xref>]. In order to facilitate swift and effective clinical outcomes, it is crucial that this disease be identified in humans [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. As shown in <xref rid="vaccines-11-00654-f001" ref-type="fig">Figure 1</xref>, there are three different methodologies that can be used to identify human brucellosis microbiologically, including culture, serology, and molecular methods. The present study provides not only a thorough assessment of the relative advantages and disadvantages of these diagnostic techniques, but also a synopsis of the recent advancements, current status, and clinical applications of these diagnostic techniques.</p>
      <sec id="sec4dot1-vaccines-11-00654">
        <title>4.1. Culturing Technique</title>
        <p>An accurate diagnosis of human brucellosis requires the identification of the etiological agent from blood, bone marrow, or other tissues and bodily fluids. Various factors contribute to the rate of bacterial isolation, including the stage of the disease, the clinical specimen, previous antibiotic use, and culture technique [<xref rid="B78-vaccines-11-00654" ref-type="bibr">78</xref>]. The isolation of the <italic toggle="yes">Brucella</italic> species is a challenging task for many researchers, and many have attempted to overcome these challenges by using techniques that directly detect them in tissues or blood. However, none of these technologies has proven more reliable and effective than the isolation of bacteria itself [<xref rid="B79-vaccines-11-00654" ref-type="bibr">79</xref>]. In spite of the lack of ideal diagnostic sensitivity, <italic toggle="yes">Brucella</italic> cultivation is more likely to occur when known techniques are employed [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. A combination of the traditional Ruiz-Castaeda biphasic technique and contemporary incubators is most effective in eliminating most of the biosafety problems associated with these pathogens. Both of these techniques detect bacterial growth without the danger of blind subcultures. When it comes to identifying brucellosis in clinical laboratories, culture is the gold standard. Since human brucellosis is always characterized by an initial bacteremic phase that precedes the development of its pathogenesis, peripheral blood cultures should always be performed as soon as cases of brucellosis are suspected [<xref rid="B32-vaccines-11-00654" ref-type="bibr">32</xref>]. Even though this method of diagnosis has a sensitivity between 10 and 90%, it is crucial for the accurate diagnosis of this disease [<xref rid="B77-vaccines-11-00654" ref-type="bibr">77</xref>]. It is possible to isolate <italic toggle="yes">Brucella</italic> species using blood cultures if serological tests are still negative or inconclusive [<xref rid="B80-vaccines-11-00654" ref-type="bibr">80</xref>,<xref rid="B81-vaccines-11-00654" ref-type="bibr">81</xref>]. </p>
        <p>Different blood culture methods have been used for the detection of <italic toggle="yes">Brucella</italic> species, such as the manual monophasic and biphasic methods [<xref rid="B82-vaccines-11-00654" ref-type="bibr">82</xref>], lysis-based blood cultures, blood clot cultures, and automated newly developed blood culture. Modern blood culture tools have improved <italic toggle="yes">Brucella</italic> species identification and improved the specificity of blood cultures [<xref rid="B83-vaccines-11-00654" ref-type="bibr">83</xref>]. The bloodstreams of patients with brucellosis initially exhibit a low bacterial burden, which cannot be revealed without following the suggested blood culture collection standards. To determine the severity of the infection, at least two or three different blood culture sets should be collected, rather than one [<xref rid="B84-vaccines-11-00654" ref-type="bibr">84</xref>]. The amount of bacteria circulating decreases as the illness worsens. In the course of the illness, the microorganism penetrates the phagocytes and multiplies, making isolation from the body difficult [<xref rid="B85-vaccines-11-00654" ref-type="bibr">85</xref>]. Standard culture practices need to be modified due to <italic toggle="yes">Brucella</italic> species&#x2019; delayed growth, low blood bacterial concentration, and carbon dioxide requirement [<xref rid="B86-vaccines-11-00654" ref-type="bibr">86</xref>]. Brucellosis of greater severity can be detected seven days after incubation, regardless of the ability of automated blood culture methods to allow five days [<xref rid="B87-vaccines-11-00654" ref-type="bibr">87</xref>]. The American Society for Microbiology and the WHO suggest that blood culture bottles be incubated for as long as one month, with blind subcultures in some cases. This protocol has many disadvantages, such as the cost and time commitment, structural difficulties, and delays in diagnostic testing [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>].</p>
        <p><italic toggle="yes">Brucella</italic> organisms can spread outside the bloodstream within 24 h of primary hematogenous dissemination in 25&#x2013;35% of patients. <italic toggle="yes">Brucella</italic> can also be isolated from other types of samples besides blood, such as bone marrow, urine, liver biopsy specimens, lymph nodes, and cerebrospinal fluid, by incubating samples in 5% CO<sub>2</sub> at 35 &#xB0;C for up to two weeks or inoculating specimens into broth media [<xref rid="B88-vaccines-11-00654" ref-type="bibr">88</xref>]. </p>
        <p><italic toggle="yes">Brucella</italic> species and their natural hosts are closely related, so it is important to quickly identify <italic toggle="yes">Brucella</italic> cultures to prevent the spread of epidemics. Identifying <italic toggle="yes">Brucella</italic> is essential for preventing biological danger, verifying the presence of the disease in its infancy stages, distinguishing between wild and vaccine strains, and monitoring the source of infection. To determine the type of <italic toggle="yes">Brucella</italic> colonies, phage lysis and oxidative metabolism profiles, carbon dioxide requirement, hydrogen sulfide production, basic fuchsin (1:50,000 and 1:100,000 dilutions), and agglutination with monospecific A and M anticseras were used [<xref rid="B89-vaccines-11-00654" ref-type="bibr">89</xref>]. Considering the disadvantages of culture techniques, such as time requirements, hazards, and insensitivity, serology should be implemented to increase sensitivity.</p>
        <p>A variety of non-phenotypic techniques can be applied to identify <italic toggle="yes">Brucella</italic> down to the species level, including matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). However, MALDI-TOF MS has a variable level of accuracy, which may put it at a disadvantage versus phenotypic techniques [<xref rid="B90-vaccines-11-00654" ref-type="bibr">90</xref>,<xref rid="B91-vaccines-11-00654" ref-type="bibr">91</xref>]. As a precaution, it is advisable to use molecular techniques to confirm the identification of <italic toggle="yes">Brucella</italic> species [<xref rid="B2-vaccines-11-00654" ref-type="bibr">2</xref>]. In some clinical medical laboratories, broth from positive culture vials or colonies developing on a plate [<xref rid="B92-vaccines-11-00654" ref-type="bibr">92</xref>] is directly injected into the MALDI-TOF matrix to reduce the time required for analysis [<xref rid="B93-vaccines-11-00654" ref-type="bibr">93</xref>,<xref rid="B94-vaccines-11-00654" ref-type="bibr">94</xref>].</p>
        <p>As a precaution against the possibility of exposure to live <italic toggle="yes">Brucella</italic> species, an intermediate step is often used to deactivate <italic toggle="yes">Brucella</italic> species by using 100% ethanol before regular protein extraction with formic acid and acetonitrile. This is an important step because it can reduce the possibility of exposure to <italic toggle="yes">Brucella</italic> species [<xref rid="B2-vaccines-11-00654" ref-type="bibr">2</xref>,<xref rid="B95-vaccines-11-00654" ref-type="bibr">95</xref>,<xref rid="B96-vaccines-11-00654" ref-type="bibr">96</xref>,<xref rid="B97-vaccines-11-00654" ref-type="bibr">97</xref>,<xref rid="B98-vaccines-11-00654" ref-type="bibr">98</xref>,<xref rid="B99-vaccines-11-00654" ref-type="bibr">99</xref>,<xref rid="B100-vaccines-11-00654" ref-type="bibr">100</xref>]. By utilizing MALDI-TOF technology, bacteria were identified at the genus and species levels. ATCC <italic toggle="yes">Brucella</italic> strains growing in synthetic blood cultures were correctly identified, and in some cases, their biovars were identified [<xref rid="B101-vaccines-11-00654" ref-type="bibr">101</xref>]. There is, however, evidence that other studies have shown that the Vitek MS system (bioM&#xE9;rieux, Craponne, France) based on the MALDI-TOF technology classified <italic toggle="yes">B. melitensis</italic> incorrectly as <italic toggle="yes">O. anthropi</italic> using accessible datasets [<xref rid="B91-vaccines-11-00654" ref-type="bibr">91</xref>]. According to Bruker Daltonics, Germany, the MALDI Biotyper purchased from that company showed inconsistent <italic toggle="yes">Brucella</italic> species differentiation, which proved that the observed protein patterns in the specimens were not sufficiently representative of the genomic evolution of <italic toggle="yes">Brucella</italic> [<xref rid="B93-vaccines-11-00654" ref-type="bibr">93</xref>,<xref rid="B100-vaccines-11-00654" ref-type="bibr">100</xref>]. A collection of 590 protein spectra was obtained from 84 <italic toggle="yes">Brucella</italic> isolates, including the most common species as well as exceptional strains, in order to build an updated Vitek MS library [<xref rid="B90-vaccines-11-00654" ref-type="bibr">90</xref>]. It was possible to distinguish clearly between <italic toggle="yes">Brucella</italic> and <italic toggle="yes">Ochrobactrum</italic> species and make identifications of the three main zoonotic species, including <italic toggle="yes">B. aborus</italic>, <italic toggle="yes">B. melitensis</italic>, and <italic toggle="yes">B. suis,</italic> due to the improved dataset. In order to independently confirm these encouraging results, a variety of wild-type isolates acquired from zoonotic and human sources with differing geographical histories must be evaluated. MALDI-TOF mass technology is advantageous in that the price per detected bacterium is low; however, this technology is expensive, which is why it is not widely available in most countries where brucellosis is prevalent [<xref rid="B100-vaccines-11-00654" ref-type="bibr">100</xref>].</p>
        <p>Among the most common causes of laboratory-acquired infections are <italic toggle="yes">Brucella</italic> species, which have a multitude of biological characteristics that make it very easy for them to spread to lab workers, resulting in an epidemic of infection [<xref rid="B102-vaccines-11-00654" ref-type="bibr">102</xref>]. Lab workers are at risk when they handle specimens containing <italic toggle="yes">Brucella</italic> species [<xref rid="B103-vaccines-11-00654" ref-type="bibr">103</xref>,<xref rid="B104-vaccines-11-00654" ref-type="bibr">104</xref>] because processes or incidents can produce aerosols that can infect blood. Several portals of entry of <italic toggle="yes">Brucellae</italic> are relevant to laboratory work, such as the respiratory tract and conjunctival epithelium, as well as the gastrointestinal tract and skin that is abraded or exposed. The attack rate in clinical microbiology laboratories can vary from 10% to 100% depending on the inoculum used, the location of workers, and the exposure source [<xref rid="B103-vaccines-11-00654" ref-type="bibr">103</xref>,<xref rid="B105-vaccines-11-00654" ref-type="bibr">105</xref>,<xref rid="B106-vaccines-11-00654" ref-type="bibr">106</xref>]. Blood cultures taken early in the course of the illness may contain high concentrations of <italic toggle="yes">Brucella</italic> organisms. Misdiagnosis and injury to laboratory personnel can occur due to Gram stain misidentification [<xref rid="B107-vaccines-11-00654" ref-type="bibr">107</xref>]. The danger of exposure is increased in underdeveloped countries because of inadequate safety equipment [<xref rid="B108-vaccines-11-00654" ref-type="bibr">108</xref>]. According to the Turkish laboratory, 10 (18%) out of 55 workers were infected with the disease, and the estimated hazard was 8% (10/125) per employee per year [<xref rid="B108-vaccines-11-00654" ref-type="bibr">108</xref>]. Lab exposures and laboratory-acquired brucellosis cases persist despite laboratory safety measures and post-exposure guidelines [<xref rid="B109-vaccines-11-00654" ref-type="bibr">109</xref>]. Several effective exposure and infection prevention strategies are available to minimize laboratory exposures to <italic toggle="yes">Brucella</italic> species and prevent other laboratory-acquired diseases. Laboratories and doctors should consult each other when identifying specimens [<xref rid="B110-vaccines-11-00654" ref-type="bibr">110</xref>]. A precaution taken in laboratory settings is to keep unidentified specimens in a biological safety cabinet until a highly contagious infection is ruled out.</p>
      </sec>
      <sec id="sec4dot2-vaccines-11-00654">
        <title>4.2. Serodiagnostic Approaches</title>
        <p>Serological tests are prioritized in human diagnosis due to being robust. However, they were standardized as diagnostic tests against animal brucellosis especially in subclinical infections; thus, the same can be achieved in humans. A number of serological tests can be used to indirectly identify particular antibodies in patients&#x2019; serum. Basically, an interpretation criterion that has been established over a long period of time is whether or not an extremely specific titer can be obtained by an agglutination test, whether there is a cutoff value in an enzyme-linked immunosorbent assay (ELISA), or whether a distinct wavelength can be detected by a lateral flow immunoassay. As a consequence of lab setting variations as well as historical and epidemiological variables (such as aging, illness duration, workplace hazards, patient demographics, endemicity, and recurrence) [<xref rid="B111-vaccines-11-00654" ref-type="bibr">111</xref>,<xref rid="B112-vaccines-11-00654" ref-type="bibr">112</xref>], these parameters are frequently contentious. Serological tests have limitations, such as their limited sensitivity, difficulty in interpreting results, and inability to differentiate between the current infection and the previously acquired infection [<xref rid="B43-vaccines-11-00654" ref-type="bibr">43</xref>]. In brucellosis-endemic areas, false positives can result from cross-reactivity with pathogens that are not targeted by the test or from the discovery of immunoglobulin that is associated with a previously exposed infection [<xref rid="B113-vaccines-11-00654" ref-type="bibr">113</xref>], which can present a major obstacle for treatment. Despite these limitations, serological tests provide an inexpensive, simple, and highly accurate diagnostic tool for the detection of human brucellosis in areas of high endemicity and a low-to-middle income level.</p>
        <p>For the detection of human brucellosis, there are numerous immunological assays available, with most of these being used for the detection of the disease in animals. The detection of non-agglutinating antibodies can be achieved through acidic pH tests (Rose Bengal test (RBT) or <italic toggle="yes">Brucella</italic>capt), Coombs tests, or immunoassays using <italic toggle="yes">Brucella</italic> lipopolysaccharides (LPS) and anti-IgG or anti-IgA conjugates [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. The complexity and inherent features of antigenic structures, such as those found in cytosolic proteins, surface proteins, and immunodominant LPS, make serological tests significant diagnostic markers. For indirect fluorescent-antibody (IFA) assays, whole cell preparations are being utilized [<xref rid="B35-vaccines-11-00654" ref-type="bibr">35</xref>]. As a matter of fact, for the laboratory diagnosis of brucellosis, the majority of serological tests are classified into two kinds of tests: those that target the brucellar smooth LPS (S-LPS) and those that target its cytosolic proteins. Smooth <italic toggle="yes">Brucella</italic> species induce a strong humoral immune response that is primarily characterized by the production of antibodies to S-LPS [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. In the first week after infection, IgM levels are elevated (which can be detected by agglutination tests such as RBT and slide agglutination test (SAT), followed by IgG1 levels in the second week, and, finally, IgG2 and IgA levels in the third week [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>]. Due to the lack of the O-polysaccharides (OPS) antigen in <italic toggle="yes">B. canis</italic>, the risk of misdiagnosis of human infection may occur [<xref rid="B114-vaccines-11-00654" ref-type="bibr">114</xref>].</p>
        <p>As a screening test for brucellosis caused by <italic toggle="yes">B. abortus</italic>, <italic toggle="yes">B. melitensis</italic>, and <italic toggle="yes">B. suis</italic> [<xref rid="B113-vaccines-11-00654" ref-type="bibr">113</xref>], the RBT, based on SAT, and a newly developed SAT miniaturized test [<xref rid="B43-vaccines-11-00654" ref-type="bibr">43</xref>,<xref rid="B115-vaccines-11-00654" ref-type="bibr">115</xref>], were used as the methodologies targeting S-LPS. In accordance with the recommendations made by numerous global institutions, the RBT should be used in combination with other methods, such as culture or other serology, for detecting human brucellosis [<xref rid="B116-vaccines-11-00654" ref-type="bibr">116</xref>,<xref rid="B117-vaccines-11-00654" ref-type="bibr">117</xref>]. It is widely believed and proven by a heavy body of literature that RBT can be used in a variety of circumstances [<xref rid="B118-vaccines-11-00654" ref-type="bibr">118</xref>,<xref rid="B119-vaccines-11-00654" ref-type="bibr">119</xref>]. Although RBT is a commonly used technique, there have been some challenges associated with it, such as misleading negative results caused by prozones and an inability to recognize non-agglutinating immunoglobulins (IgA/IgG) [<xref rid="B43-vaccines-11-00654" ref-type="bibr">43</xref>]. The RBT has demonstrated a high level of specificity in some studies; however, the application process of the RBT to healthcare settings has encountered a number of known obstacles. Its strong agglutinating activity makes IgM most effective in areas nearby hospitals. It is still possible for SAT to produce false-negative findings, even under these conditions, if the incubation period of the disease is prolonged [<xref rid="B79-vaccines-11-00654" ref-type="bibr">79</xref>]. Due to the predominance of non-agglutinating antibodies in long-evolution cases, the diagnostic performance of SAT is poor in areas with restricted access to medical facilities. The SAT with serum dilution, however, remains an effective diagnostic tool when necessary precautions are taken, as it overcomes the issues of blocking antibodies and prozone, is cost-effective, and is not overly complex. </p>
        <p>The fine chemical structure of the OPS of the LPS determines the serospecificity of the bacteria [<xref rid="B120-vaccines-11-00654" ref-type="bibr">120</xref>]. The application of serial dilutions to RBT with a 1:8 cut-off increases the specificity of the test without a significant loss of sensitivity, complexity, or time [<xref rid="B113-vaccines-11-00654" ref-type="bibr">113</xref>]. In addition to the detection of cytosolic proteins using ELISA, the same method has been successfully used for the detection of neuro-brucellosis in cerebrospinal fluid [<xref rid="B121-vaccines-11-00654" ref-type="bibr">121</xref>] and to identify immunoglobulins in different animal hosts and humans [<xref rid="B122-vaccines-11-00654" ref-type="bibr">122</xref>,<xref rid="B123-vaccines-11-00654" ref-type="bibr">123</xref>,<xref rid="B124-vaccines-11-00654" ref-type="bibr">124</xref>]. The ELISA assay previously demonstrated exceptional sensitivity (98.3%) and specificity (99.7%) for detection of human brucellosis [<xref rid="B125-vaccines-11-00654" ref-type="bibr">125</xref>]. High cost and infrastructure requirements make ELISA a secondary test in healthcare settings with low incomes [<xref rid="B126-vaccines-11-00654" ref-type="bibr">126</xref>]. As an initial screening method, it is possible to quickly detect brucellosis using a portable quantum dot immunochromatographic test strip. This is an easy and convenient method, and is available nowadays [<xref rid="B127-vaccines-11-00654" ref-type="bibr">127</xref>]. Unlike enzyme immunoassays and lateral flow immunochromatography, agglutination-based assays do not have the capability of distinguishing between different types of antibodies present, which makes them less accurate [<xref rid="B32-vaccines-11-00654" ref-type="bibr">32</xref>]. As a result of the achievements of increased sensitivity, rapid and accurate results, a reduction in costs, and easy implementation of these antigenic assays, experimental antigenic assays have been developed, such as synthetic oligosaccharides and recombinant <italic toggle="yes">Brucella</italic> proteins [<xref rid="B128-vaccines-11-00654" ref-type="bibr">128</xref>].</p>
      </sec>
      <sec id="sec4dot3-vaccines-11-00654">
        <title>4.3. Genotypic Approaches</title>
        <p>Genomic techniques can be utilized to detect brucellosis, both in humans and in animals, with great accuracy and speed. The capability of genotypic approaches to be successful for a considerable amount of time remains to be a significant advantage when clinical significance is ambiguous and individuals appear to be asymptomatic. There is, how-ever, the possibility that a positive result does not always mean that an infection is continuing. A significantly reduced bacterial inoculum may reflect a bacterial inoculum in routinely subjected normal individuals, DNA from dead organisms, or patients who have had adequate treatment for their ailments. Although serological tests and very sensitive nucleic acid amplification techniques have become increasingly common for the laboratory diagnosis of brucellosis, cultures remain the &#x201C;gold standard&#x201D; due to their clinical and epidemiological relevance [<xref rid="B32-vaccines-11-00654" ref-type="bibr">32</xref>]. Due to the specific nature of molecular approaches, findings from these approaches should be carefully interpreted, keeping in mind the relevant clinical and epidemiological contexts at all times. Molecular brucellosis testing has consistently shown that serum samples have a superior yield when used first on peripheral circulation with satisfactory completion, as they are an optimal sample for molecular analysis of human brucellosis [<xref rid="B129-vaccines-11-00654" ref-type="bibr">129</xref>,<xref rid="B130-vaccines-11-00654" ref-type="bibr">130</xref>]. Brucellosis may also be genetically characterized with samples obtained from the cardiac, urogenital, bone marrow, and peripheral nervous systems, which can aid in diagnosing focal brucellosis affecting any tissues or organs where civilizations are frequently negative [<xref rid="B131-vaccines-11-00654" ref-type="bibr">131</xref>,<xref rid="B132-vaccines-11-00654" ref-type="bibr">132</xref>]. The DNA extracted from formalin-fixed paraffin-embedded tissue was also tested in accordance with the approved DNA extraction procedures [<xref rid="B133-vaccines-11-00654" ref-type="bibr">133</xref>].</p>
        <p>It has been reported that many molecular tests are used to identify genes that are responsible for making outer membrane proteins. A few of the more important genes are <italic toggle="yes">OMP2</italic> and <italic toggle="yes">OMP31,</italic> as well as the <italic toggle="yes">omp28</italic> gene, which is also called the <italic toggle="yes">bp26</italic> gene [<xref rid="B134-vaccines-11-00654" ref-type="bibr">134</xref>,<xref rid="B135-vaccines-11-00654" ref-type="bibr">135</xref>]. There are a few other gene targets that may be utilized for the molecular diagnosis of <italic toggle="yes">Brucella</italic> infection besides <italic toggle="yes">16S rRNA</italic> and the insertion sequence <italic toggle="yes">IS711</italic>, as cross-reactions have been detected in both genes. As a result of the fluctuation of <italic toggle="yes">IS711</italic> sequences and its absence in some strains, its performance has been questioned. In addition to being highly immunogenic, the most commonly selected gene, <italic toggle="yes">bcsp31</italic>, is also responsible for producing an immunogenic membrane protein [<xref rid="B134-vaccines-11-00654" ref-type="bibr">134</xref>,<xref rid="B136-vaccines-11-00654" ref-type="bibr">136</xref>,<xref rid="B137-vaccines-11-00654" ref-type="bibr">137</xref>]. In molecular techniques, there is a wide variety of amplification methodologies used to achieve amplification of DNA. Real-time PCR, quantitative RT-PCR, multiplex RT-PCR, nested PCR, in-house PCR, PCR-enzyme immunoassay in a microplate format, and traditional PCR procedures are some of the amplification methodology methods used [<xref rid="B76-vaccines-11-00654" ref-type="bibr">76</xref>,<xref rid="B138-vaccines-11-00654" ref-type="bibr">138</xref>]. Using a multiplex PCR assay, it is possible to develop a simple and easy one-step test for the detection of <italic toggle="yes">Brucella</italic> in a sample with significantly higher accuracy than traditional testing methods [<xref rid="B139-vaccines-11-00654" ref-type="bibr">139</xref>,<xref rid="B140-vaccines-11-00654" ref-type="bibr">140</xref>,<xref rid="B141-vaccines-11-00654" ref-type="bibr">141</xref>]. There are many advantages of this assay: in comparison with previously developed PCRs, the main one is its ability to distinguish between <italic toggle="yes">Brucella</italic> species and vaccine strains (S19, RB51, and Rev. 1) in a single step [<xref rid="B142-vaccines-11-00654" ref-type="bibr">142</xref>]. In addition, certain technologies have recently been developed for the detection of <italic toggle="yes">Brucella</italic> species, the most recent being a loop-mediated isothermal amplification (LAMP) method. Compared to PCR, the LAMP assay offers superior results due to its ease of use, ease of assembly, rapid response time, and visual recognition. Because of its simplicity and the low cost of the equipment used, including a laboratory water bath that maintains a stable temperature of 63 &#xB0;C, it is well suited to the purpose of the test [<xref rid="B143-vaccines-11-00654" ref-type="bibr">143</xref>]. A LAMP test can be performed without the need for electrophoretic analysis, which is in contrast to PCR testing [<xref rid="B144-vaccines-11-00654" ref-type="bibr">144</xref>]. The LAMP assay is highly sensitive and specific, and can be completed in less than an hour [<xref rid="B145-vaccines-11-00654" ref-type="bibr">145</xref>]. It is also more cost-effective than alternative molecular techniques, since it does not require the use of expensive equipment or reagents. It can, therefore, be used in areas where resources are limited but the need for quick and accurate diagnosis is high.</p>
        <p>Currently, there are very few competitive genetic methods for detecting brucellosis in both humans and animals, and there are hardly any comparative studies that have compared the effectiveness of commercial and homemade molecular methods. In addition, sometimes the results are based on very small sample sizes, making it difficult to find comparative studies [<xref rid="B146-vaccines-11-00654" ref-type="bibr">146</xref>,<xref rid="B147-vaccines-11-00654" ref-type="bibr">147</xref>]. </p>
        <p>By sequencing, it is possible to discover molecular mechanisms that explain variations of biotypes and evolutionary relationships for human brucellosis [<xref rid="B148-vaccines-11-00654" ref-type="bibr">148</xref>,<xref rid="B149-vaccines-11-00654" ref-type="bibr">149</xref>]. Identifying these targets could be a significant step forward in the development of diagnoses and vaccinations aimed at combating and treating brucellosis [<xref rid="B150-vaccines-11-00654" ref-type="bibr">150</xref>]. As part of the diagnosis process, it is necessary to use expensive, specialized equipment that is difficult to obtain. In low-income countries, the current availability of next-generation sequencing technologies is woefully insufficient to meet the requirements for research carried out in those countries. The fact that there is no specific test for definitively identifying a bacterium is the primary reason for the necessary integration of multiple techniques for <italic toggle="yes">Brucella&#x2019;</italic>s diagnosis [<xref rid="B149-vaccines-11-00654" ref-type="bibr">149</xref>,<xref rid="B151-vaccines-11-00654" ref-type="bibr">151</xref>,<xref rid="B152-vaccines-11-00654" ref-type="bibr">152</xref>]. Although there are valid and reliable advertising and home-made molecular techniques that can ensure a high degree of accuracy and precision of results, conventional methods of culture and indirect methods of serology continue to be the primary methods of diagnosing brucellosis and following up on infections caused by <italic toggle="yes">Brucella</italic> species.</p>
      </sec>
    </sec>
    <sec id="sec5-vaccines-11-00654">
      <title>5. <italic toggle="yes">Brucella</italic> Vaccine Development</title>
      <sec id="sec5dot1-vaccines-11-00654">
        <title>5.1. Availability of Human Vaccines</title>
        <p>Vaccination has been well-established to be a crucial element in the control and prevention of brucellosis [<xref rid="B153-vaccines-11-00654" ref-type="bibr">153</xref>,<xref rid="B154-vaccines-11-00654" ref-type="bibr">154</xref>,<xref rid="B155-vaccines-11-00654" ref-type="bibr">155</xref>]. Currently, there is no human vaccine available for brucellosis, and the animal vaccines that are available have been deemed unsuitable for use by the general population due to concern regarding the possibility of causing serious illness [<xref rid="B156-vaccines-11-00654" ref-type="bibr">156</xref>]. Therefore, this has led to an increase in interest from researchers in developing a vaccine to prevent humans from contracting brucellosis. Despite the lack of a safe and effective <italic toggle="yes">Brucella</italic> vaccine for humans, animal vaccinations are essential not only to safeguard animal health, but also to prevent the spreading of diseases transmitted from animals to humans. Several drawbacks of these vaccines have been reported by Darbandi et al. [<xref rid="B157-vaccines-11-00654" ref-type="bibr">157</xref>]. Among these are: (i) they remain virulent in humans; (ii) they cause abortion in pregnant animals; (iii) it can be difficult to differentiate between infected and vaccinated animals due to the persistent serological response they induce; (iv) they are relatively unstable. However, a variety of vaccines have been developed so far to be used in humans, yet each of these vaccines has drawbacks that make their application difficult. In the case of the S19 <italic toggle="yes">B. abortus</italic> vaccine, for instance, which is administered subcutaneously by scarification, there is very limited immunity for a short period of time and it is very important to receive booster doses on a regular basis. An additional problem with this type of vaccine is its tendency to cause hypersensitivity reactivity. In general, <italic toggle="yes">B. abortus</italic> 84-C and M-104 have been found to be safe when administered intradermally or by spray, but this is not to say that they cannot cause serious reactions if improperly administered or if they are applied to susceptible individuals [<xref rid="B153-vaccines-11-00654" ref-type="bibr">153</xref>].</p>
      </sec>
      <sec id="sec5dot2-vaccines-11-00654">
        <title>5.2. Live Attenuated Vaccines: Policies and Limitations</title>
        <p><italic toggle="yes">Brucella</italic> vaccines (usually live attenuated strains) play a critical role in combating brucellosis by endowing animals with immune protection and prevention of the spread of disease on farms. Most importantly, animal vaccination reduces abortion risks and thereby increases environmental safety. Currently, there are three different types of vaccines that are being distributed across the world against animal brucellosis: <italic toggle="yes">B. abortus</italic> S19 and <italic toggle="yes">B. abortus</italic> RB51, which are for cattle; and <italic toggle="yes">B. melitensis</italic> Rev. 1, which is for small ruminants [<xref rid="B71-vaccines-11-00654" ref-type="bibr">71</xref>]. Each of them is known to be 70% effective and has been administered efficiently; however, due to residual pathogenicity, which could cause illnesses to emerge, they are not suitable for use in humans [<xref rid="B155-vaccines-11-00654" ref-type="bibr">155</xref>]. The S19 vaccine is still the most cost-effective vaccine for the prevention of <italic toggle="yes">B. abortus</italic> infection in cattle at present. The RB51 strain of <italic toggle="yes">B. abortus</italic>, a spontaneous R-mutant, is used as a live vaccine, and is less effective (requires revaccination) and more expensive compared to other live vaccines. </p>
        <p>With the implementation of eradication programs, the use of the S19 and RB51 vaccines, as well as Rev. 1 in small ruminants, will become difficult because these vaccines produce antibodies that can be detected through serological tests [<xref rid="B71-vaccines-11-00654" ref-type="bibr">71</xref>,<xref rid="B158-vaccines-11-00654" ref-type="bibr">158</xref>]. These vaccines, however, are subject to some limitations that make their use difficult; for example, S19 and Rev. 1 may cause abortion in pregnant animals, and antibody titers resulting from vaccination may persist for a prolonged period in vaccinated animals [<xref rid="B159-vaccines-11-00654" ref-type="bibr">159</xref>,<xref rid="B160-vaccines-11-00654" ref-type="bibr">160</xref>]. Therefore, a safe vaccination approach, such as limiting animal age at vaccination and using a single full-dose lifetime protocol, will reduce the risks associated with persistent antibodies. Moreover, in some regions, repeated vaccination protocols at two-year intervals can be recommended in order to increase herd vaccination coverage.</p>
        <p><italic toggle="yes">B. abortus</italic> RB51 has been used since 2002 instead of <italic toggle="yes">B. abortus</italic> S19 for the vaccination of cattle [<xref rid="B71-vaccines-11-00654" ref-type="bibr">71</xref>,<xref rid="B161-vaccines-11-00654" ref-type="bibr">161</xref>]. The RB51 vaccine has more recently been widely distributed in sub-Saharan African nations [<xref rid="B162-vaccines-11-00654" ref-type="bibr">162</xref>]. Blasco [<xref rid="B163-vaccines-11-00654" ref-type="bibr">163</xref>] found that conjunctival vaccination with Rev. 1 effectively suppresses <italic toggle="yes">B. melitensis</italic> infection in sheep and goats, unlike rough RB51. Another study revealed that the RB51 vaccine is effective in controlling brucellosis in cattle regardless of the species [<xref rid="B164-vaccines-11-00654" ref-type="bibr">164</xref>]. </p>
        <p>One of the most promising strains of SR-<italic toggle="yes">B. abortus,</italic> which was discovered in Russia, is strain 82. In 1961, Salmakov discovered this strain through the selection of colonies derived from an aborted bovine fetus [<xref rid="B165-vaccines-11-00654" ref-type="bibr">165</xref>]. Vaccine strain 75/79-AB of <italic toggle="yes">B. abortus</italic> with marginal agglutinogenic properties was another strain that was used in the field regarding <italic toggle="yes">B. abortus</italic> vaccination in the Russian Federation. Its use was coordinated according to the results of serological testing within three months of immunization, and vaccination of pregnant heifers occurred regardless of gestational stage [<xref rid="B166-vaccines-11-00654" ref-type="bibr">166</xref>,<xref rid="B167-vaccines-11-00654" ref-type="bibr">167</xref>,<xref rid="B168-vaccines-11-00654" ref-type="bibr">168</xref>]. The <italic toggle="yes">B. abortus</italic> 104 M vaccine has a long history of being used in China for the prevention of brucellosis since 1965 [<xref rid="B72-vaccines-11-00654" ref-type="bibr">72</xref>]. As far as safety is concerned, this strain has been poorly defined, is hard to find, and is not readily accessible. In order to develop an effective and safe brucellosis vaccine for the general public, extensive research is necessary. There is a live attenuated <italic toggle="yes">B. suis</italic> vaccine known as the <italic toggle="yes">B. suis</italic> S2 that is the most widely used brucellosis vaccine in China [<xref rid="B169-vaccines-11-00654" ref-type="bibr">169</xref>].</p>
        <p>Recently, there are numerous strategies that have been put forward to eradicate brucellosis. Among these are the limitation of animal translocation from diseased herds to healthy ones, the use of live vaccines such as S19 and Rev. 1, and a substantial preventative coverage, as well as the proper diagnostic methods. Vaccination has several advantages, such as preventing the spread of infection between humans and animals, reducing the incidence of brucellosis, reducing shedding rates among animals, and disrupting the ability to transmit diseases from one animal to another [<xref rid="B170-vaccines-11-00654" ref-type="bibr">170</xref>]. There may be some drawbacks to vaccination, including the development of field strains that are persistent or resistant to the immunity provided by the vaccination, the risk of unrecognized latency which may burst later on, and contribution to the false impression that infection has been beaten by vaccination [<xref rid="B171-vaccines-11-00654" ref-type="bibr">171</xref>]. </p>
      </sec>
      <sec id="sec5dot3-vaccines-11-00654">
        <title>5.3. Novel Vaccines with Recombinant Genes, Proteins and Vectors</title>
        <p>The economic losses resulting from common illnesses between humans and animals [<xref rid="B172-vaccines-11-00654" ref-type="bibr">172</xref>,<xref rid="B173-vaccines-11-00654" ref-type="bibr">173</xref>] is motivating investigators to investigate vaccine candidates such as subunit vaccines [<xref rid="B174-vaccines-11-00654" ref-type="bibr">174</xref>], bacterial vector-based vaccines [<xref rid="B175-vaccines-11-00654" ref-type="bibr">175</xref>], and vaccinations utilizing overexpression of protective homologous antigens [<xref rid="B173-vaccines-11-00654" ref-type="bibr">173</xref>]. There is a wide range of genes that have recently been used, including L7/L12, BLS, BCSP31, SOD Cu/Zn, Omp16, P39, and BAB1-0278. It is generally not necessary to use adjuvants in DNA vaccinations [<xref rid="B155-vaccines-11-00654" ref-type="bibr">155</xref>]. It has been proven that the DNA vaccine for <italic toggle="yes">B. abortus</italic>, BAB1-0278, protects mice against infection. The effects of DNA vaccines containing BAB1 0273 and/or BAB1 0278 and SOD C on mice are low, although they induce immune responses [<xref rid="B176-vaccines-11-00654" ref-type="bibr">176</xref>]. A DNA vaccine candidate for p39 and/or groEL, together with other DNA-based vaccine candidates, needs to be repeated a number of times despite the fact that it provides only modest-level control. As a result, there is still much work to be accomplished in this field [<xref rid="B177-vaccines-11-00654" ref-type="bibr">177</xref>]. In order to improve the immune function of <italic toggle="yes">Brucella</italic> DNA vaccines and improve their effectiveness, it is recommended that cytokines be developed as adjuvants (SOD with IL-18 or IL-12), and a number of antigens could be incorporated into DNA vaccines (Omp16 and L7/L12) [<xref rid="B155-vaccines-11-00654" ref-type="bibr">155</xref>].</p>
      </sec>
      <sec id="sec5dot4-vaccines-11-00654">
        <title>5.4. Expectations for Development Human Brucellosis Vaccines </title>
        <p>For the development of new <italic toggle="yes">Brucella</italic> vaccines, it is essential that the pathogenicity of the bacteria and the host be thoroughly analyzed. DNA vaccines are suitable for diseases that require cellular immunity. Human studies have shown that these vaccines induce weaker immune responses than mice; therefore, they need to be optimized [<xref rid="B157-vaccines-11-00654" ref-type="bibr">157</xref>]. Optimization, however, increases pro-inflammatory reactions [<xref rid="B178-vaccines-11-00654" ref-type="bibr">178</xref>]. New optimization methods can be used to improve delivery and codon optimization [<xref rid="B179-vaccines-11-00654" ref-type="bibr">179</xref>]. There are many methods that can be used to accelerate the development of a <italic toggle="yes">Brucella</italic> vaccine, including signature transposon mutagenesis with transposon tags, green fluorescent protein-expressing <italic toggle="yes">Brucella</italic> strains, and knockout mice. Using a broad genomic analysis and bacterial imaging both in vitro and in vivo, knockout mice and other genetically manipulated mice can be used to increase the likelihood of discovering weak strains as well as to speed up the pace of vaccine production [<xref rid="B180-vaccines-11-00654" ref-type="bibr">180</xref>]. It is important to consider many factors when developing <italic toggle="yes">Brucella</italic> vaccines: first, how to obtain authorization; second, evaluating the vaccine&#x2019;s effectiveness in two experimental animals, a mouse and a monkey; and, finally, testing the vaccine for safety, immunogenicity, and effectiveness. A preventive measure should be expected to have an impact when it is impossible to test and demonstrate its efficacy on humans [<xref rid="B156-vaccines-11-00654" ref-type="bibr">156</xref>]. </p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec6-vaccines-11-00654">
      <title>6. Conclusions</title>
      <p>Although brucellosis is a rare infection that can be transmitted from person to person, it is a zoonotic infection that can be transmitted to humans from infected animals. There is a common view among the medical community that the main method of eradicating this disease in humans is through widespread vaccination of animals, along with testing and slaughtering. A culture remains the &#x201C;gold standard&#x201D; for brucellosis diagnosis even though serological markers and nucleic acid amplification techniques have been extensively used in the laboratory diagnosis of brucellosis. Despite this, serological tests are still commonly used in endemic regions because they are low-cost, user-friendly, and robust in predicting negative results. In addition, because of their high sensitivity and specificity, molecular approaches can be used as quick tests to detect brucellosis within a few hours. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Generally, live-attenuated vaccines, commonly known as <italic toggle="yes">B. abortus</italic> strain S19 and <italic toggle="yes">B. melitensis</italic> strain Rev. 1, are one of the most popular ways to immunize animals around the world against brucellosis. Nonetheless, they have several disadvantages, including the induction of abortion in pregnant animals, pathogenicity for humans, the development of anti-<italic toggle="yes">Brucella</italic> antibodies that interfered with the serodiagnosis of brucellosis, and resistance to antibiotics used to treat brucellosis. Currently, there is no vaccine available against human brucellosis. In this regard, vaccination-based control of animal brucellosis has contributed significantly to human brucellosis management.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors extend their appreciation to the Deputyship for Research &amp; Innovation, Ministry of Education, Saudi Arabia for funding this research work through the project number (QU-IF-5-2-4-33856). </p>
    </ack>
    <fn-group>
      <fn>
        <p><bold>Disclaimer/Publisher&#x2019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p>
      </fn>
    </fn-group>
    <notes>
      <title>Author Contributions</title>
      <p>Conceptualization, A.E., M.A. (Musaad Aldubaib), E.M., A.A. A.M.A., M.R., A.A. (Ali Alghamdi), and A.D.; validation, A.E., M.A. (Musaad Aldubaib), E.M., A.A. (Adil Abalkhail), A.M.A., M.R., A.A. (Ali Alghamdi), A.A. (Abdullah Alqarni), M.A. (Mohammed Aldawsari) and A.D.; resources, A.E., M.A. (Musaad Aldubaib), E.M., A.A. (Adil Abalkhail), A.M.A., M.R., A.A. (Ali Alghamdi), A.A. (Abdullah Alqarni), M.A. (Mohammed Aldawsari) and A.D.; data curation, A.E., M.A. (Musaad Aldubaib), E.M., A.A. (Adil Abalkhail), A.M.A., M.R., M.A. (Mohammed Aldawsari) and A.D.; writing&#x2014;original draft preparation, A.E., E.M., A.A. (Adil Abalkhail), A.M.A., M.R., A.A. (Ali Alghamdi), A.A. (Abdullah Alqarni), M.A. (Mohammed Aldawsari) and A.D.; writing&#x2014;review and editing, A.E., M.A. (Musaad Aldubaib), E.M., A.A. (Adil Abalkhail), A.M.A., M.R., A.A. (Ali Alghamdi), A.A. (Abdullah Alqarni), M.A. (Mohammed Aldawsari) and A.D.; visualization, A.E., M.A. (Musaad Aldubaib), E.M., A.A. (Adil Abalkhail), A.M.A., M.R., A.A. (Ali Alghamdi), A.A. (Abdullah Alqarni), M.A. (Mohammed Aldawsari) and A.D.; supervision, A.E., M.A. (Musaad Aldubaib) and E.M. All authors have read and agreed to the published version of the manuscript. </p>
    </notes>
    <notes>
      <title>Institutional Review Board Statement</title>
      <p>Not applicable.</p>
    </notes>
    <notes>
      <title>Informed Consent Statement</title>
      <p>Not applicable.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data Availability Statement</title>
      <p>Not applicable.</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-vaccines-11-00654">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Ri</surname><given-names>M.J.</given-names></name>
<name><surname>Cui</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>A man with recurrent fever, arthritis, and rashes-brucellosis? A case report</article-title>
          <source>BMC Infect. Dis.</source>
          <year>2020</year>
          <volume>20</volume>
          <elocation-id>18</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s12879-019-4746-0</pub-id>
          <pub-id pub-id-type="pmid">31910802</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-vaccines-11-00654">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Aldubaib</surname><given-names>M.</given-names></name>
<name><surname>Al Rugaie</surname><given-names>O.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Abaalkhail</surname><given-names>M.</given-names></name>
<name><surname>Moussa</surname><given-names>I.</given-names></name>
<name><surname>El-Husseiny</surname><given-names>M.H.</given-names></name>
<name><surname>Abalkhail</surname><given-names>A.</given-names></name>
<name><surname>Rawway</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical <italic toggle="yes">Brucella</italic> species: An evolution of brucellosis infection control</article-title>
          <source>PLoS ONE</source>
          <year>2022</year>
          <volume>17</volume>
          <elocation-id>e0262551</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0262551</pub-id>
          <pub-id pub-id-type="pmid">35025975</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-vaccines-11-00654">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Aldubaib</surname><given-names>M.</given-names></name>
<name><surname>Al Rugaie</surname><given-names>O.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Moussa</surname><given-names>I.</given-names></name>
<name><surname>El-Husseiny</surname><given-names>M.</given-names></name>
<name><surname>Ibrahem</surname><given-names>M.</given-names></name>
<name><surname>Abalkhail</surname><given-names>A.</given-names></name>
<name><surname>Rawway</surname><given-names>M.</given-names></name>
</person-group>
          <article-title><italic toggle="yes">Brucella</italic> species-induced brucellosis: Antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles</article-title>
          <source>PLoS ONE</source>
          <year>2022</year>
          <volume>17</volume>
          <elocation-id>e0269963</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0269963</pub-id>
          <pub-id pub-id-type="pmid">35834538</pub-id>
        </element-citation>
      </ref>
      <ref id="B4-vaccines-11-00654">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Khan</surname><given-names>M.Z.</given-names></name>
<name><surname>Zahoor</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies</article-title>
          <source>Trop. Med. Infect. Dis.</source>
          <year>2018</year>
          <volume>3</volume>
          <elocation-id>65</elocation-id>
          <pub-id pub-id-type="doi">10.3390/tropicalmed3020065</pub-id>
          <pub-id pub-id-type="pmid">30274461</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-vaccines-11-00654">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>O&#x2019;Callaghan</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Human brucellosis: Recent advances and future challenges</article-title>
          <source>Infect. Dis. Poverty</source>
          <year>2020</year>
          <volume>9</volume>
          <fpage>1</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1186/s40249-020-00715-1</pub-id>
          <pub-id pub-id-type="pmid">31996251</pub-id>
        </element-citation>
      </ref>
      <ref id="B6-vaccines-11-00654">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wareth</surname><given-names>G.</given-names></name>
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Ali</surname><given-names>H.</given-names></name>
<name><surname>Hamdy</surname><given-names>M.E.R.</given-names></name>
<name><surname>Al-Talhy</surname><given-names>A.M.</given-names></name>
<name><surname>Elkharsawi</surname><given-names>A.R.</given-names></name>
<name><surname>El Tawab</surname><given-names>A.A.A.</given-names></name>
<name><surname>Neubauer</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management</article-title>
          <source>Transbound. Emerg. Dis.</source>
          <year>2022</year>
          <volume>69</volume>
          <fpage>e1253</fpage>
          <lpage>e1268</lpage>
          <pub-id pub-id-type="doi">10.1111/tbed.14502</pub-id>
          <pub-id pub-id-type="pmid">35244335</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-vaccines-11-00654">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pourbagher</surname><given-names>A.</given-names></name>
<name><surname>Pourbagher</surname><given-names>M.A.</given-names></name>
<name><surname>Savas</surname><given-names>L.</given-names></name>
<name><surname>Turunc</surname><given-names>T.</given-names></name>
<name><surname>Demiroglu</surname><given-names>Y.Z.</given-names></name>
<name><surname>Erol</surname><given-names>I.</given-names></name>
<name><surname>Yalcintas</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Epidemiologic, Clinical, and Imaging Findings in Brucellosis Patients with Osteoarticular Involvement</article-title>
          <source>Am. J. Roentgenol.</source>
          <year>2006</year>
          <volume>187</volume>
          <fpage>873</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="doi">10.2214/AJR.05.1088</pub-id>
          <pub-id pub-id-type="pmid">16985128</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-vaccines-11-00654">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Musallam</surname><given-names>I.I.</given-names></name>
<name><surname>Abo-Shehada</surname><given-names>M.N.</given-names></name>
<name><surname>Hegazy</surname><given-names>Y.M.</given-names></name>
<name><surname>Holt</surname><given-names>H.R.</given-names></name>
<name><surname>Guitian</surname><given-names>F.J.</given-names></name>
</person-group>
          <article-title>Systematic review of brucellosis in the Middle East: Disease frequency in ruminants and humans and risk factors for human infection</article-title>
          <source>Epidemiol. Infect.</source>
          <year>2015</year>
          <volume>144</volume>
          <fpage>671</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="doi">10.1017/S0950268815002575</pub-id>
          <pub-id pub-id-type="pmid">26508323</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-vaccines-11-00654">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nejad</surname><given-names>R.B.</given-names></name>
<name><surname>Krecek</surname><given-names>R.C.</given-names></name>
<name><surname>Khalaf</surname><given-names>O.</given-names></name>
<name><surname>Hailat</surname><given-names>N.</given-names></name>
<name><surname>Arenas-Gamboa</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Brucellosis in the Middle East: Current situation and a pathway forward</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2020</year>
          <volume>14</volume>
          <elocation-id>e0008071</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0008071</pub-id>
          <pub-id pub-id-type="pmid">32437346</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-vaccines-11-00654">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Tazerart</surname><given-names>F.</given-names></name>
<name><surname>Aliouane</surname><given-names>K.</given-names></name>
<name><surname>Grine</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Animal and human brucellosis in Algeria: A review</article-title>
          <source>New Microbes New Infect.</source>
          <year>2022</year>
          <volume>46</volume>
          <fpage>100975</fpage>
          <pub-id pub-id-type="doi">10.1016/j.nmni.2022.100975</pub-id>
          <pub-id pub-id-type="pmid">35496669</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-vaccines-11-00654">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Teka</surname><given-names>D.</given-names></name>
<name><surname>Tadesse</surname><given-names>B.</given-names></name>
<name><surname>Kinfe</surname><given-names>G.</given-names></name>
<name><surname>Denberga</surname><given-names>Y.</given-names></name>
</person-group>
          <article-title>Sero-prevalence of bovine brucellosis and its associated risk factors in Becho District, South West Shewa, Oromia regional state</article-title>
          <source>ARC J. Anim. Vet. Sci.</source>
          <year>2019</year>
          <volume>5</volume>
          <fpage>35</fpage>
          <lpage>45</lpage>
        </element-citation>
      </ref>
      <ref id="B12-vaccines-11-00654">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Saxena</surname><given-names>N.</given-names></name>
<name><surname>Singh</surname><given-names>B.B.</given-names></name>
<name><surname>Saxena</surname><given-names>H.M.</given-names></name>
</person-group>
          <article-title>Brucellosis in Sheep and Goats and its Serodiagnosis and Epidemiology</article-title>
          <source>Int. J. Curr. Microbiol. Appl. Sci.</source>
          <year>2018</year>
          <volume>7</volume>
          <fpage>1848</fpage>
          <lpage>1877</lpage>
          <pub-id pub-id-type="doi">10.20546/ijcmas.2018.701.225</pub-id>
        </element-citation>
      </ref>
      <ref id="B13-vaccines-11-00654">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Franc</surname><given-names>K.A.</given-names></name>
<name><surname>Krecek</surname><given-names>R.C.</given-names></name>
<name><surname>H&#xE4;sler</surname><given-names>B.N.</given-names></name>
<name><surname>Arenas-Gamboa</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Brucellosis remains a neglected disease in the developing world: A call for interdisciplinary action</article-title>
          <source>BMC Public Health</source>
          <year>2018</year>
          <volume>18</volume>
          <elocation-id>125</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s12889-017-5016-y</pub-id>
          <pub-id pub-id-type="pmid">29325516</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-vaccines-11-00654">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yuguda</surname><given-names>M.U.</given-names></name>
<name><surname>Sundaram</surname><given-names>S.</given-names></name>
<name><surname>Lakshmanan</surname><given-names>G.</given-names></name>
<name><surname>Ayyasamy</surname><given-names>E.</given-names></name>
<name><surname>Purushothaman</surname><given-names>S.</given-names></name>
<name><surname>Kannan</surname><given-names>P.</given-names></name>
<name><surname>Sanjeevi</surname><given-names>T.</given-names></name>
</person-group>
          <article-title>Serosurveillance of Bovine Brucellosis Using RBPT and c-ELISA and Comparative Evaluation of Test Performance</article-title>
          <source>Int. J. Curr. Microbiol. Appl. Sci.</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>559</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="doi">10.20546/ijcmas.2019.808.067</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-vaccines-11-00654">
        <label>15.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>K.J.</given-names></name>
<name><surname>Ray</surname><given-names>C.G.</given-names></name>
</person-group>
          <source>Medical Microbiology</source>
          <publisher-name>McGraw Hill</publisher-name>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <year>2004</year>
          <volume>Volume 4</volume>
        </element-citation>
      </ref>
      <ref id="B16-vaccines-11-00654">
        <label>16.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Terwagne</surname><given-names>M.</given-names></name>
<name><surname>Uzureau</surname><given-names>S.</given-names></name>
<name><surname>Letesson</surname><given-names>J.-J.</given-names></name>
</person-group>
          <source>Brucella: Molecular Microbiology and Genomics</source>
          <publisher-name>Caister Academic Press</publisher-name>
          <publisher-loc>Poole, UK</publisher-loc>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="B17-vaccines-11-00654">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ferooz</surname><given-names>J.</given-names></name>
<name><surname>Letesson</surname><given-names>J.-J.</given-names></name>
</person-group>
          <article-title>Morphological analysis of the sheathed flagellum of <italic toggle="yes">Brucella melitensis</italic></article-title>
          <source>BMC Res. Notes</source>
          <year>2010</year>
          <volume>3</volume>
          <elocation-id>333</elocation-id>
          <pub-id pub-id-type="doi">10.1186/1756-0500-3-333</pub-id>
          <pub-id pub-id-type="pmid">21143933</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-vaccines-11-00654">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Scholz</surname><given-names>H.C.</given-names></name>
<name><surname>M&#xFC;hldorfer</surname><given-names>K.</given-names></name>
<name><surname>Shilton</surname><given-names>C.</given-names></name>
<name><surname>Benedict</surname><given-names>S.</given-names></name>
<name><surname>Whatmore</surname><given-names>A.M.</given-names></name>
<name><surname>Blom</surname><given-names>J.</given-names></name>
<name><surname>Eisenberg</surname><given-names>T.</given-names></name>
</person-group>
          <article-title>The Change of a Medically Important Genus: Worldwide Occurrence of Genetically Diverse Novel <italic toggle="yes">Brucella</italic> Species in Exotic Frogs</article-title>
          <source>PLoS ONE</source>
          <year>2016</year>
          <volume>11</volume>
          <elocation-id>e0168872</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0168872</pub-id>
          <pub-id pub-id-type="pmid">28036367</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-vaccines-11-00654">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Su&#xE1;rez-Esquivel</surname><given-names>M.</given-names></name>
<name><surname>Baker</surname><given-names>K.S.</given-names></name>
<name><surname>Ruiz-Villalobos</surname><given-names>N.</given-names></name>
<name><surname>Hern&#xE1;ndez-Mora</surname><given-names>G.</given-names></name>
<name><surname>Barquero-Calvo</surname><given-names>E.</given-names></name>
<name><surname>Gonz&#xE1;lez-Barrientos</surname><given-names>R.</given-names></name>
<name><surname>Castillo-Zeled&#xF3;n</surname><given-names>A.</given-names></name>
<name><surname>Jim&#xE9;nez-Rojas</surname><given-names>C.</given-names></name>
<name><surname>Chac&#xF3;n-D&#xED;az</surname><given-names>C.</given-names></name>
<name><surname>Cloeckaert</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title><italic toggle="yes">Brucella</italic> Genetic Variability in Wildlife Marine Mammals Populations Relates to Host Preference and Ocean Distribution</article-title>
          <source>Genome Biol. Evol.</source>
          <year>2017</year>
          <volume>9</volume>
          <fpage>1901</fpage>
          <lpage>1912</lpage>
          <pub-id pub-id-type="doi">10.1093/gbe/evx137</pub-id>
          <pub-id pub-id-type="pmid">28854602</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-vaccines-11-00654">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sohn</surname><given-names>A.H.</given-names></name>
<name><surname>Probert</surname><given-names>W.S.</given-names></name>
<name><surname>Glaser</surname><given-names>C.A.</given-names></name>
<name><surname>Gupta</surname><given-names>N.</given-names></name>
<name><surname>Bollen</surname><given-names>A.W.</given-names></name>
<name><surname>Wong</surname><given-names>J.D.</given-names></name>
<name><surname>Grace</surname><given-names>E.M.</given-names></name>
<name><surname>McDonald</surname><given-names>W.C.</given-names></name>
</person-group>
          <article-title>Human neurobrucellosis with intracerebral granuloma caused by a marine mammal <italic toggle="yes">Brucella</italic> spp</article-title>
          <source>Emerg. Infect. Dis.</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>485</fpage>
          <pub-id pub-id-type="doi">10.3201/eid0904.020576</pub-id>
          <pub-id pub-id-type="pmid">12702232</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-vaccines-11-00654">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Li</surname><given-names>S.-Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.-E.</given-names></name>
<name><surname>Chen</surname><given-names>J.-Y.</given-names></name>
<name><surname>Lai</surname><given-names>C.-H.</given-names></name>
<name><surname>Mao</surname><given-names>Y.-C.</given-names></name>
<name><surname>Huang</surname><given-names>Y.-T.</given-names></name>
<name><surname>Liu</surname><given-names>P.-Y.</given-names></name>
</person-group>
          <article-title>Genomics of <italic toggle="yes">Ochrobactrum pseudogrignonense</italic> (newly named <italic toggle="yes">Brucella pseudogrignonensis</italic>) reveals a new bla OXA subgroup</article-title>
          <source>Microb. Genom.</source>
          <year>2021</year>
          <volume>7</volume>
          <fpage>626</fpage>
          <pub-id pub-id-type="doi">10.1099/mgen.0.000626</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-vaccines-11-00654">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Leclercq</surname><given-names>S.O.</given-names></name>
<name><surname>Cloeckaert</surname><given-names>A.</given-names></name>
<name><surname>Zygmunt</surname><given-names>M.S.</given-names></name>
</person-group>
          <article-title>Taxonomic Organization of the Family <italic toggle="yes">Brucellaceae</italic> Based on a Phylogenomic Approach</article-title>
          <source>Front. Microbiol.</source>
          <year>2020</year>
          <volume>10</volume>
          <fpage>3083</fpage>
          <pub-id pub-id-type="doi">10.3389/fmicb.2019.03083</pub-id>
          <pub-id pub-id-type="pmid">32082266</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-vaccines-11-00654">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>M.</given-names></name>
<name><surname>Pembroke</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>The Genus <italic toggle="yes">Ochrobactrum</italic> as Major Opportunistic Pathogens</article-title>
          <source>Microorganisms</source>
          <year>2020</year>
          <volume>8</volume>
          <elocation-id>1797</elocation-id>
          <pub-id pub-id-type="doi">10.3390/microorganisms8111797</pub-id>
          <pub-id pub-id-type="pmid">33207839</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-vaccines-11-00654">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lai</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
</person-group>
          <article-title>Human brucellosis: An ongoing global health challenge</article-title>
          <source>China CDC Wkly.</source>
          <year>2021</year>
          <volume>3</volume>
          <fpage>120</fpage>
          <pub-id pub-id-type="pmid">34595017</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-vaccines-11-00654">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lokamar</surname><given-names>P.N.</given-names></name>
<name><surname>Kutwah</surname><given-names>M.A.</given-names></name>
<name><surname>Atieli</surname><given-names>H.</given-names></name>
<name><surname>Gumo</surname><given-names>S.</given-names></name>
<name><surname>Ouma</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Socio-economic impacts of brucellosis on livestock production and reproduction performance in Koibatek and Marigat regions, Baringo County, Kenya</article-title>
          <source>BMC Veter. Res.</source>
          <year>2020</year>
          <volume>16</volume>
          <elocation-id>61</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s12917-020-02283-w</pub-id>
          <pub-id pub-id-type="pmid">32070337</pub-id>
        </element-citation>
      </ref>
      <ref id="B26-vaccines-11-00654">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dereje</surname><given-names>T.</given-names></name>
<name><surname>Benti</surname><given-names>D.</given-names></name>
<name><surname>Feyisa</surname><given-names>B.</given-names></name>
<name><surname>Abiy</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Review of common causes of abortion in dairy cattle in Ethiopia</article-title>
          <source>J. Veter. Med. Anim. Health</source>
          <year>2018</year>
          <volume>10</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.5897/JVMAH2017.0639</pub-id>
        </element-citation>
      </ref>
      <ref id="B27-vaccines-11-00654">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>El-Diasty</surname><given-names>M.</given-names></name>
<name><surname>El-Said</surname><given-names>R.</given-names></name>
<name><surname>Abdelkhalek</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Seroprevalence and molecular diagnosis of sheep brucellosis in Dakahlia governorate, Egypt</article-title>
          <source>Ger. J. Veter. Res.</source>
          <year>2021</year>
          <volume>1</volume>
          <fpage>34</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.51585/gjvr.2021.0006</pub-id>
        </element-citation>
      </ref>
      <ref id="B28-vaccines-11-00654">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dione</surname><given-names>M.M.</given-names></name>
<name><surname>S&#xE9;ry</surname><given-names>A.</given-names></name>
<name><surname>Sidib&#xE9;</surname><given-names>C.A.K.</given-names></name>
<name><surname>Wieland</surname><given-names>B.</given-names></name>
<name><surname>Fall</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Exposure to multiple pathogens-serological evidence for Rift Valley fever virus, <italic toggle="yes">Coxiella burnetii</italic>, <italic toggle="yes">Bluetongue virus</italic> and <italic toggle="yes">Brucella</italic> spp. in cattle, sheep and goat in Mali</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2022</year>
          <volume>16</volume>
          <elocation-id>e0010342</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0010342</pub-id>
          <pub-id pub-id-type="pmid">35486653</pub-id>
        </element-citation>
      </ref>
      <ref id="B29-vaccines-11-00654">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Shahali</surname><given-names>Y.</given-names></name>
<name><surname>Whatmore</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Human brucellosis caused by raw dairy products: A review on the occurrence, major risk factors and prevention</article-title>
          <source>Int. J. Food Microbiol.</source>
          <year>2018</year>
          <volume>292</volume>
          <fpage>39</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2018.12.009</pub-id>
          <pub-id pub-id-type="pmid">30572264</pub-id>
        </element-citation>
      </ref>
      <ref id="B30-vaccines-11-00654">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Maichomo</surname><given-names>M.W.</given-names></name>
<name><surname>McDermott</surname><given-names>J.J.</given-names></name>
<name><surname>Arimi</surname><given-names>S.M.</given-names></name>
<name><surname>Gathura</surname><given-names>P.B.</given-names></name>
<name><surname>Mugambi</surname><given-names>T.J.</given-names></name>
<name><surname>Muriuki</surname><given-names>S.M.</given-names></name>
</person-group>
          <article-title>Study of brucellosis in a pastoral community and evaluation of the usefulness of clinical signs and symptoms in differentiating it from other flu-like diseases</article-title>
          <source>Afr. J. Health Sci.</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>114</fpage>
          <lpage>119</lpage>
        </element-citation>
      </ref>
      <ref id="B31-vaccines-11-00654">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Franco</surname><given-names>M.P.</given-names></name>
<name><surname>Mulder</surname><given-names>M.</given-names></name>
<name><surname>Smits</surname><given-names>H.L.</given-names></name>
</person-group>
          <article-title>Persistence and relapse in brucellosis and need for improved treatment</article-title>
          <source>Trans. R. Soc. Trop. Med. Hyg.</source>
          <year>2007</year>
          <volume>101</volume>
          <fpage>854</fpage>
          <lpage>855</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trstmh.2007.05.016</pub-id>
          <pub-id pub-id-type="pmid">17604065</pub-id>
        </element-citation>
      </ref>
      <ref id="B32-vaccines-11-00654">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Di Bonaventura</surname><given-names>G.</given-names></name>
<name><surname>Angeletti</surname><given-names>S.</given-names></name>
<name><surname>Ianni</surname><given-names>A.</given-names></name>
<name><surname>Petitti</surname><given-names>T.</given-names></name>
<name><surname>Gherardi</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview</article-title>
          <source>Pathogens</source>
          <year>2021</year>
          <volume>10</volume>
          <elocation-id>1623</elocation-id>
          <pub-id pub-id-type="doi">10.3390/pathogens10121623</pub-id>
          <pub-id pub-id-type="pmid">34959578</pub-id>
        </element-citation>
      </ref>
      <ref id="B33-vaccines-11-00654">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pickett</surname><given-names>M.</given-names></name>
<name><surname>Calderone</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Criteria for identification of <italic toggle="yes">Brucella</italic> species</article-title>
          <source>Am. J. Public Health Nations Health</source>
          <year>1963</year>
          <volume>53</volume>
          <fpage>655</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.53.4.655</pub-id>
          <pub-id pub-id-type="pmid">18017982</pub-id>
        </element-citation>
      </ref>
      <ref id="B34-vaccines-11-00654">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Smirnova</surname><given-names>E.A.</given-names></name>
<name><surname>Vasin</surname><given-names>A.V.</given-names></name>
<name><surname>Sandybaev</surname><given-names>N.T.</given-names></name>
<name><surname>Klotchenko</surname><given-names>S.A.</given-names></name>
<name><surname>Plotnikova</surname><given-names>M.A.</given-names></name>
<name><surname>Chervyakova</surname><given-names>O.V.</given-names></name>
<name><surname>Sansyzbay</surname><given-names>A.R.</given-names></name>
<name><surname>Kiselev</surname><given-names>O.I.</given-names></name>
</person-group>
          <article-title>Current Methods of Human and Animal Brucellosis Diagnostics</article-title>
          <source>Adv. Infect. Dis.</source>
          <year>2013</year>
          <volume>03</volume>
          <fpage>177</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.4236/aid.2013.33026</pub-id>
        </element-citation>
      </ref>
      <ref id="B35-vaccines-11-00654">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Araj</surname><given-names>G.F.</given-names></name>
</person-group>
          <article-title>Update on laboratory diagnosis of human brucellosis</article-title>
          <source>Int. J. Antimicrob. Agents</source>
          <year>2010</year>
          <volume>36</volume>
          <fpage>S12</fpage>
          <lpage>S17</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.06.014</pub-id>
          <pub-id pub-id-type="pmid">20692128</pub-id>
        </element-citation>
      </ref>
      <ref id="B36-vaccines-11-00654">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Minda</surname><given-names>A.G.</given-names></name>
<name><surname>Gezahegne</surname><given-names>M.K.</given-names></name>
</person-group>
          <article-title>A review on diagnostic methods of brucellosis</article-title>
          <source>J. Vet. Sci. Technol.</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
        </element-citation>
      </ref>
      <ref id="B37-vaccines-11-00654">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pastorino</surname><given-names>B.</given-names></name>
<name><surname>De Lamballerie</surname><given-names>X.</given-names></name>
<name><surname>Charrel</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements</article-title>
          <source>Front. Public Health</source>
          <year>2017</year>
          <volume>5</volume>
          <fpage>121</fpage>
          <pub-id pub-id-type="doi">10.3389/fpubh.2017.00121</pub-id>
          <pub-id pub-id-type="pmid">28620600</pub-id>
        </element-citation>
      </ref>
      <ref id="B38-vaccines-11-00654">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Casalinuovo</surname><given-names>F.</given-names></name>
<name><surname>Ciambrone</surname><given-names>L.</given-names></name>
<name><surname>Cacia</surname><given-names>A.</given-names></name>
<name><surname>Rippa</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Contamination of Bovine, Sheep and Goat Meat with <italic toggle="yes">Brucella</italic> Spp</article-title>
          <source>Ital. J. Food Saf.</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>5913</fpage>
          <pub-id pub-id-type="doi">10.4081/ijfs.2016.5913</pub-id>
          <pub-id pub-id-type="pmid">27853716</pub-id>
        </element-citation>
      </ref>
      <ref id="B39-vaccines-11-00654">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Tabibi</surname><given-names>R.</given-names></name>
<name><surname>Alamian</surname><given-names>S.</given-names></name>
<name><surname>Caraballo-Arias</surname><given-names>Y.</given-names></name>
<name><surname>Mrema</surname><given-names>E.J.</given-names></name>
<name><surname>Mlimbila</surname><given-names>J.</given-names></name>
<name><surname>Chandrasekar</surname><given-names>S.</given-names></name>
<name><surname>Dzhusupov</surname><given-names>K.</given-names></name>
<name><surname>Sulaimanova</surname><given-names>C.</given-names></name>
<name><surname>Alekesheva</surname><given-names>L.Z.</given-names></name>
<etal/>
</person-group>
          <article-title>Safety concerns and potential hazards of occupational brucellosis in developing countries: A review</article-title>
          <source>J. Public Health</source>
          <year>2022</year>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1007/s10389-022-01732-0</pub-id>
        </element-citation>
      </ref>
      <ref id="B40-vaccines-11-00654">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>C.R.</given-names></name>
<name><surname>Cotrim de Almeida</surname><given-names>J.V.F.</given-names></name>
<name><surname>Cardoso de Oliveira</surname><given-names>I.R.</given-names></name>
<name><surname>Faria de Oliveira</surname><given-names>L.</given-names></name>
<name><surname>Pereira</surname><given-names>L.J.</given-names></name>
<name><surname>Zangeronimo</surname><given-names>M.G.</given-names></name>
<name><surname>Lage</surname><given-names>A.P.</given-names></name>
<name><surname>Dorneles</surname><given-names>E.M.S.</given-names></name>
</person-group>
          <article-title>Occupational exposure to <italic toggle="yes">Brucella</italic> spp.: A systematic review and meta-analysis</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2020</year>
          <volume>14</volume>
          <elocation-id>e0008164</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0008164</pub-id>
          <pub-id pub-id-type="pmid">32392223</pub-id>
        </element-citation>
      </ref>
      <ref id="B41-vaccines-11-00654">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Rossetti</surname><given-names>C.A.</given-names></name>
<name><surname>Arenas-Gamboa</surname><given-names>A.M.</given-names></name>
<name><surname>Maurizio</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Caprine brucellosis: A historically neglected disease with significant impact on public health</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2017</year>
          <volume>11</volume>
          <elocation-id>e0005692</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0005692</pub-id>
          <pub-id pub-id-type="pmid">28817647</pub-id>
        </element-citation>
      </ref>
      <ref id="B42-vaccines-11-00654">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bosilkovski</surname><given-names>M.</given-names></name>
<name><surname>Keramat</surname><given-names>F.</given-names></name>
<name><surname>Arapovi&#x107;</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>The current therapeutical strategies in human brucellosis</article-title>
          <source>Infection</source>
          <year>2021</year>
          <volume>49</volume>
          <fpage>823</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="doi">10.1007/s15010-021-01586-w</pub-id>
          <pub-id pub-id-type="pmid">33650077</pub-id>
        </element-citation>
      </ref>
      <ref id="B43-vaccines-11-00654">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Al Dahouk</surname><given-names>S.</given-names></name>
<name><surname>N&#xF6;ckler</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Implications of laboratory diagnosis on brucellosis therapy</article-title>
          <source>Expert Rev. Anti-Infect. Ther.</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>833</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="doi">10.1586/eri.11.55</pub-id>
          <pub-id pub-id-type="pmid">21810055</pub-id>
        </element-citation>
      </ref>
      <ref id="B44-vaccines-11-00654">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Doganay</surname><given-names>M.</given-names></name>
<name><surname>Aygen</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Human brucellosis: An overview</article-title>
          <source>Int. J. Infect. Dis.</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>173</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1016/S1201-9712(03)90049-X</pub-id>
        </element-citation>
      </ref>
      <ref id="B45-vaccines-11-00654">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Jiang</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Lan</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group>
          <article-title>Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China</article-title>
          <source>BMC Infect. Dis.</source>
          <year>2019</year>
          <volume>19</volume>
          <elocation-id>439</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s12879-019-4081-5</pub-id>
          <pub-id pub-id-type="pmid">31109292</pub-id>
        </element-citation>
      </ref>
      <ref id="B46-vaccines-11-00654">
        <label>46.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Corbel</surname><given-names>M.J.</given-names></name>
</person-group>
          <source>Brucellosis in Humans and Animals</source>
          <publisher-name>World Health Organization</publisher-name>
          <publisher-loc>Geneva, Switzerland</publisher-loc>
          <year>2006</year>
        </element-citation>
      </ref>
      <ref id="B47-vaccines-11-00654">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Heidary</surname><given-names>M.</given-names></name>
<name><surname>Dashtbin</surname><given-names>S.</given-names></name>
<name><surname>Ghanavati</surname><given-names>R.</given-names></name>
<name><surname>Ari</surname><given-names>M.M.</given-names></name>
<name><surname>Bostanghadiri</surname><given-names>N.</given-names></name>
<name><surname>Darbandi</surname><given-names>A.</given-names></name>
<name><surname>Navidifar</surname><given-names>T.</given-names></name>
<name><surname>Talebi</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Evaluation of Brucellosis Vaccines: A Comprehensive Review</article-title>
          <source>Front. Veter. Sci.</source>
          <year>2022</year>
          <volume>9</volume>
          <fpage>925773</fpage>
          <pub-id pub-id-type="doi">10.3389/fvets.2022.925773</pub-id>
        </element-citation>
      </ref>
      <ref id="B48-vaccines-11-00654">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Marston</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Report on fever (Malta)</article-title>
          <source>Army Med. Dep. Rep.</source>
          <year>1861</year>
          <volume>3</volume>
          <fpage>486</fpage>
          <lpage>521</lpage>
        </element-citation>
      </ref>
      <ref id="B49-vaccines-11-00654">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Memish</surname><given-names>Z.A.</given-names></name>
<name><surname>Balkhy</surname><given-names>H.H.</given-names></name>
</person-group>
          <article-title>Brucellosis and International Travel</article-title>
          <source>J. Travel Med.</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>49</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.2310/7060.2004.13551</pub-id>
          <pub-id pub-id-type="pmid">14769288</pub-id>
        </element-citation>
      </ref>
      <ref id="B50-vaccines-11-00654">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Akpinar</surname><given-names>O.</given-names></name>
</person-group>
          <article-title>Historical perspective of brucellosis: A microbiological and epidemiological overview</article-title>
          <source>Infez. Med.</source>
          <year>2016</year>
          <volume>24</volume>
          <fpage>77</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">27031903</pub-id>
        </element-citation>
      </ref>
      <ref id="B51-vaccines-11-00654">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Tazerart</surname><given-names>F.</given-names></name>
<name><surname>Aliouane</surname><given-names>K.</given-names></name>
<name><surname>Grine</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Erratum to &#x201C;Evolution of animal and human brucellosis in Algeria: A mini narrative review: Anerni n tawla n Mal&#x1E6D;a n yi&#x263;ersiwen d yimdanen di Lezzayer: Tas&#x263;unt tanalasant tilem&#x1E93;it&#x201D;</article-title>
          <source>New Microbes New Infect.</source>
          <year>2022</year>
          <volume>48</volume>
          <fpage>100975</fpage>
          <pub-id pub-id-type="doi">10.1016/j.nmni.2022.100975</pub-id>
        </element-citation>
      </ref>
      <ref id="B52-vaccines-11-00654">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bang</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>The etiology of epizootic abortion</article-title>
          <source>J. Comp. Pathol. Ther.</source>
          <year>1897</year>
          <volume>10</volume>
          <fpage>125</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1016/S0368-1742(97)80014-8</pub-id>
        </element-citation>
      </ref>
      <ref id="B53-vaccines-11-00654">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Evans</surname><given-names>A.C.</given-names></name>
</person-group>
          <article-title>Brucellosis in the United States</article-title>
          <source>Am. J. Public Health Nations Health</source>
          <year>1947</year>
          <volume>37</volume>
          <fpage>139</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.37.2.139</pub-id>
        </element-citation>
      </ref>
      <ref id="B54-vaccines-11-00654">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Binek</surname><given-names>M.</given-names></name>
<name><surname>Kizerwetter-&#x15A;wida</surname><given-names>M.</given-names></name>
<name><surname>Chrobak-Chmiel</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Wk&#x142;ad mikrobiologii weterynaryjnej w budow&#x119; idei wsp&#xF3;lnego zdrowia</article-title>
          <source>Adv. Microbiol.</source>
          <year>2018</year>
          <volume>57</volume>
          <fpage>95</fpage>
          <lpage>105</lpage>
        </element-citation>
      </ref>
      <ref id="B55-vaccines-11-00654">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Weight</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>On the application of the serum test to the differential diagnosis of typhoid and malta fever: And on the further application of the method of serum diagnosis to the elucidation of certain problems in connexion with the duration of immunity and the geographical distribution of disease</article-title>
          <source>Lancet</source>
          <year>1897</year>
          <volume>149</volume>
          <fpage>656</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="doi">10.1016/s0140-6736(00)49007-0</pub-id>
        </element-citation>
      </ref>
      <ref id="B56-vaccines-11-00654">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Tan</surname><given-names>S.Y.</given-names></name>
<name><surname>Davis</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>David Bruce (1855&#x2013;1931): Discoverer of brucellosis</article-title>
          <source>Singap. Med. J.</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>138</fpage>
          <lpage>139</lpage>
        </element-citation>
      </ref>
      <ref id="B57-vaccines-11-00654">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Moreno</surname><given-names>E.</given-names></name>
<name><surname>Moriy&#xF3;n</surname><given-names>I.</given-names></name>
</person-group>
          <article-title><italic toggle="yes">Brucella melitensis</italic>: A nasty bug with hidden credentials for virulence</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>1</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.022622699</pub-id>
          <pub-id pub-id-type="pmid">11782541</pub-id>
        </element-citation>
      </ref>
      <ref id="B58-vaccines-11-00654">
        <label>58.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Young</surname><given-names>E.J.</given-names></name>
</person-group>
          <article-title>Brucella species</article-title>
          <source>Principles and Practice of Infectious Diseases</source>
          <edition>6th ed.</edition>
          <person-group person-group-type="editor">
<name><surname>Mandell</surname><given-names>G.L.</given-names></name>
<name><surname>Bennett</surname><given-names>J.E.</given-names></name>
<name><surname>Dolin</surname><given-names>R.</given-names></name>
</person-group>
          <publisher-name>Churchill Livingstone</publisher-name>
          <publisher-loc>Philadelphia, PA, USA</publisher-loc>
          <year>2005</year>
          <fpage>2669</fpage>
          <lpage>2674</lpage>
        </element-citation>
      </ref>
      <ref id="B59-vaccines-11-00654">
        <label>59.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Murray</surname><given-names>P.R.</given-names></name>
<name><surname>Rosenthal</surname><given-names>K.S.</given-names></name>
<name><surname>Pfaller</surname><given-names>M.A.</given-names></name>
</person-group>
          <source>Medical Microbiology</source>
          <publisher-name>Mosby</publisher-name>
          <publisher-loc>Philadelphia, PA, USA</publisher-loc>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="B60-vaccines-11-00654">
        <label>60.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Benhabyles</surname><given-names>N.</given-names></name>
<name><surname>Benkirane</surname><given-names>A.</given-names></name>
<name><surname>Boudilmi</surname><given-names>B.</given-names></name>
<name><surname>Benchouk</surname><given-names>S.</given-names></name>
<name><surname>Bouayoun</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Epidemiology of human and animal brucellosis in the Maghreb</article-title>
          <source>Prevention of Brucellosis in the Mediterranean Countries: Proceedings of the International Seminar, Valletta, Malta</source>
          <publisher-name>CIHEAM Publication</publisher-name>
          <publisher-loc>Paris, France</publisher-loc>
          <year>1992</year>
          <fpage>31157082021</fpage>
          <comment>Available online: <ext-link xlink:href="http://edepot.wur.nl/311570" ext-link-type="uri">http://edepot.wur.nl/311570</ext-link></comment>
          <date-in-citation content-type="access-date" iso-8601-date="2021-01-08">(accessed on 8 January 2021)</date-in-citation>
        </element-citation>
      </ref>
      <ref id="B61-vaccines-11-00654">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Benelmouffok</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Bovine brucellosis in Algeria. Results of serological detection from 1969 to 1976</article-title>
          <source>Arch. De L'institut Pasteur D'algerie. Inst. Pasteur D'algerie</source>
          <year>1978</year>
          <volume>53</volume>
          <fpage>120</fpage>
          <lpage>126</lpage>
        </element-citation>
      </ref>
      <ref id="B62-vaccines-11-00654">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Refai</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Incidence and control of brucellosis in the Near East region</article-title>
          <source>Veter. Microbiol.</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>81</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00248-1</pub-id>
        </element-citation>
      </ref>
      <ref id="B63-vaccines-11-00654">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kiros</surname><given-names>A.</given-names></name>
<name><surname>Asgedom</surname><given-names>H.</given-names></name>
<name><surname>Abdi</surname><given-names>R.D.</given-names></name>
</person-group>
          <article-title>A review on bovine brucellosis: Epidemiology, diagnosis and control options</article-title>
          <source>ARC J. Anim. Vet. Sci.</source>
          <year>2016</year>
          <volume>2</volume>
          <fpage>8</fpage>
          <lpage>21</lpage>
        </element-citation>
      </ref>
      <ref id="B64-vaccines-11-00654">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Shahali</surname><given-names>Y.</given-names></name>
<name><surname>Alamian</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Isolation of <italic toggle="yes">Brucella melitensis</italic> biovar 1 from human milk confirms breastfeeding as a possible route for infant infection</article-title>
          <source>Microb. Pathog.</source>
          <year>2021</year>
          <volume>157</volume>
          <fpage>104958</fpage>
          <pub-id pub-id-type="doi">10.1016/j.micpath.2021.104958</pub-id>
          <pub-id pub-id-type="pmid">34029659</pub-id>
        </element-citation>
      </ref>
      <ref id="B65-vaccines-11-00654">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Almofada</surname><given-names>S.</given-names></name>
<name><surname>Al-Eissa</surname><given-names>Y.A.</given-names></name>
<name><surname>Saeed</surname><given-names>E.S.</given-names></name>
<name><surname>Kambal</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Isolation of <italic toggle="yes">Brucella melitensis</italic> from human milk</article-title>
          <source>J. Infect.</source>
          <year>1993</year>
          <volume>26</volume>
          <fpage>346</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="doi">10.1016/0163-4453(93)96165-M</pub-id>
          <pub-id pub-id-type="pmid">8505580</pub-id>
        </element-citation>
      </ref>
      <ref id="B66-vaccines-11-00654">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>McDermott</surname><given-names>J.</given-names></name>
<name><surname>Grace</surname><given-names>D.</given-names></name>
<name><surname>Zinsstag</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Economics of brucellosis impact and control in low-income countries</article-title>
          <source>Rev. Sci. Tech. Int. Off. Epizoot.</source>
          <year>2013</year>
          <volume>32</volume>
          <fpage>249</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.20506/rst.32.1.2197</pub-id>
        </element-citation>
      </ref>
      <ref id="B67-vaccines-11-00654">
        <label>67.</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
<collab>European Centre for Disease Prevention and Control</collab>
</person-group>
          <article-title>Brucellosis&#x2014;Annual Epidemiological Report for 2017</article-title>
          <comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/sites/default/files/documents/brucellosis-annual-epidemiological-report-2017.pdf" ext-link-type="uri">https://www.ecdc.europa.eu/sites/default/files/documents/brucellosis-annual-epidemiological-report-2017.pdf</ext-link></comment>
          <date-in-citation content-type="access-date" iso-8601-date="2021-01-08">(accessed on 8 January 2021)</date-in-citation>
        </element-citation>
      </ref>
      <ref id="B68-vaccines-11-00654">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Galeano</surname><given-names>C.R.</given-names></name>
<name><surname>Mojica</surname><given-names>C.P.</given-names></name>
<name><surname>Rojas</surname><given-names>O.A.</given-names></name>
<name><surname>Z&#xFA;&#xF1;iga</surname><given-names>J.J.R.</given-names></name>
</person-group>
          <article-title>Aspectos epidemiol&#xF3;gicos de la brucelosis en humanos en las &#xC1;reas Rectoras Aguas Zarcas y Los Chiles, Costa Rica, 2015&#x2013;2017</article-title>
          <source>Cienc. Vet.</source>
          <year>2020</year>
          <volume>38</volume>
          <fpage>1</fpage>
          <lpage>16</lpage>
        </element-citation>
      </ref>
      <ref id="B69-vaccines-11-00654">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Avila-Granados</surname><given-names>L.M.</given-names></name>
<name><surname>Garcia-Gonzalez</surname><given-names>D.G.</given-names></name>
<name><surname>Zambrano-Varon</surname><given-names>J.L.</given-names></name>
<name><surname>Arenas-Gamboa</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Brucellosis in Colombia: Current Status and Challenges in the Control of an Endemic Disease</article-title>
          <source>Front. Veter. Sci.</source>
          <year>2019</year>
          <volume>6</volume>
          <fpage>321</fpage>
          <pub-id pub-id-type="doi">10.3389/fvets.2019.00321</pub-id>
        </element-citation>
      </ref>
      <ref id="B70-vaccines-11-00654">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Luna-Mart&#x131;nez</surname><given-names>J.</given-names></name>
<name><surname>Mej&#x131;a-Ter&#xE1;n</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Brucellosis in Mexico: Current status and trends</article-title>
          <source>Veter. Microbiol.</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>19</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00241-9</pub-id>
        </element-citation>
      </ref>
      <ref id="B71-vaccines-11-00654">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ducrotoy</surname><given-names>M.</given-names></name>
<name><surname>Bertu</surname><given-names>W.</given-names></name>
<name><surname>Matope</surname><given-names>G.</given-names></name>
<name><surname>Cadmus</surname><given-names>S.</given-names></name>
<name><surname>Conde-&#xC1;lvarez</surname><given-names>R.</given-names></name>
<name><surname>Gusi</surname><given-names>A.</given-names></name>
<name><surname>Welburn</surname><given-names>S.</given-names></name>
<name><surname>Ocholi</surname><given-names>R.</given-names></name>
<name><surname>Blasco</surname><given-names>J.</given-names></name>
<name><surname>Moriy&#xF3;n</surname><given-names>I.</given-names></name>
</person-group>
          <article-title>Brucellosis in Sub-Saharan Africa: Current challenges for management, diagnosis and control</article-title>
          <source>Acta Trop.</source>
          <year>2017</year>
          <volume>165</volume>
          <fpage>179</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="doi">10.1016/j.actatropica.2015.10.023</pub-id>
          <pub-id pub-id-type="pmid">26551794</pub-id>
        </element-citation>
      </ref>
      <ref id="B72-vaccines-11-00654">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>H.</given-names></name>
<name><surname>O&#x2019;Callaghan</surname><given-names>D.</given-names></name>
<name><surname>Ding</surname><given-names>J.-B.</given-names></name>
</person-group>
          <article-title>Brucellosis in China: History, progress and challenge</article-title>
          <source>Infect. Dis. Poverty</source>
          <year>2020</year>
          <volume>9</volume>
          <fpage>101</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.1186/s40249-020-00673-8</pub-id>
          <pub-id pub-id-type="pmid">32703319</pub-id>
        </element-citation>
      </ref>
      <ref id="B73-vaccines-11-00654">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lai</surname><given-names>S.</given-names></name>
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Xiong</surname><given-names>W.</given-names></name>
<name><surname>Gilbert</surname><given-names>M.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Yu</surname><given-names>J.</given-names></name>
<name><surname>Yin</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<etal/>
</person-group>
          <article-title>Changing Epidemiology of Human Brucellosis, China, 1955&#x2013;2014</article-title>
          <source>Emerg. Infect. Dis.</source>
          <year>2017</year>
          <volume>23</volume>
          <fpage>184</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.3201/eid2302.151710</pub-id>
          <pub-id pub-id-type="pmid">28098531</pub-id>
        </element-citation>
      </ref>
      <ref id="B74-vaccines-11-00654">
        <label>74.</label>
        <element-citation publication-type="gov">
          <person-group person-group-type="author">
<collab>Ministry of Agriculture and Rural Affairs of China</collab>
</person-group>
          <article-title>National Brucellosis Control Program, 2016&#x2013;2020</article-title>
          <year>2020</year>
          <comment>Available online: <ext-link xlink:href="http://www.moa.gov.cn/govpublic/SYJ/201609/t20160909_5270524.htm" ext-link-type="uri">http://www.moa.gov.cn/govpublic/SYJ/201609/t20160909_5270524.htm</ext-link></comment>
          <date-in-citation content-type="access-date" iso-8601-date="2021-01-10">(accessed on 10 January 2021)</date-in-citation>
        </element-citation>
      </ref>
      <ref id="B75-vaccines-11-00654">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Godfroid</surname><given-names>J.</given-names></name>
<name><surname>Al Dahouk</surname><given-names>S.</given-names></name>
<name><surname>Pappas</surname><given-names>G.</given-names></name>
<name><surname>Roth</surname><given-names>F.</given-names></name>
<name><surname>Matope</surname><given-names>G.</given-names></name>
<name><surname>Muma</surname><given-names>J.</given-names></name>
<name><surname>Marcotty</surname><given-names>T.</given-names></name>
<name><surname>Pfeiffer</surname><given-names>D.</given-names></name>
<name><surname>Skjerve</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>A &#x201C;One Health&#x201D; surveillance and control of brucellosis in developing countries: Moving away from improvisation</article-title>
          <source>Comp. Immunol. Microbiol. Infect. Dis.</source>
          <year>2013</year>
          <volume>36</volume>
          <fpage>241</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cimid.2012.09.001</pub-id>
          <pub-id pub-id-type="pmid">23044181</pub-id>
        </element-citation>
      </ref>
      <ref id="B76-vaccines-11-00654">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
<name><surname>Morata</surname><given-names>P.</given-names></name>
<name><surname>Colmenero</surname><given-names>J.D.</given-names></name>
</person-group>
          <article-title>Laboratory Diagnosis of Human Brucellosis</article-title>
          <source>Clin. Microbiol. Rev.</source>
          <year>2019</year>
          <volume>33</volume>
          <fpage>e00073-19</fpage>
          <pub-id pub-id-type="doi">10.1128/CMR.00073-19</pub-id>
          <pub-id pub-id-type="pmid">31722888</pub-id>
        </element-citation>
      </ref>
      <ref id="B77-vaccines-11-00654">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>G.</given-names></name>
<name><surname>Akritidis</surname><given-names>N.</given-names></name>
<name><surname>Bosilkovski</surname><given-names>M.</given-names></name>
<name><surname>Tsianos</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>The b. <italic toggle="yes">melitens</italic> is genome</article-title>
          <source>N. Engl. J. Med.</source>
          <year>2005</year>
          <volume>352</volume>
          <fpage>2325</fpage>
          <lpage>2336</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra050570</pub-id>
          <pub-id pub-id-type="pmid">15930423</pub-id>
        </element-citation>
      </ref>
      <ref id="B78-vaccines-11-00654">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Al Dahouk</surname><given-names>S.</given-names></name>
<name><surname>Tomaso</surname><given-names>H.</given-names></name>
<name><surname>N&#xF6;ckler</surname><given-names>K.</given-names></name>
<name><surname>Neubauer</surname><given-names>H.</given-names></name>
<name><surname>Frangoulidis</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Laboratory-based diagnosis of brucellosis&#x2014;A review of the literature. Part II: Serological tests for brucellosis</article-title>
          <source>Clin. Lab.</source>
          <year>2003</year>
          <volume>49</volume>
          <fpage>577</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">14651329</pub-id>
        </element-citation>
      </ref>
      <ref id="B79-vaccines-11-00654">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Moreno</surname><given-names>E.</given-names></name>
<name><surname>Blasco</surname><given-names>J.-M.</given-names></name>
<name><surname>Moriy&#xF3;n</surname><given-names>I.</given-names></name>
</person-group>
          <article-title>Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons</article-title>
          <source>Microorganisms</source>
          <year>2022</year>
          <volume>10</volume>
          <elocation-id>942</elocation-id>
          <pub-id pub-id-type="doi">10.3390/microorganisms10050942</pub-id>
          <pub-id pub-id-type="pmid">35630386</pub-id>
        </element-citation>
      </ref>
      <ref id="B80-vaccines-11-00654">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Tang</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Evaluation of a hypervariable octameric oligonucleotide fingerprints assay for identification of and discrimination between wild-type and vaccine strains of <italic toggle="yes">Brucella melitensis</italic></article-title>
          <source>Am. J. Veter. Res.</source>
          <year>2017</year>
          <volume>78</volume>
          <fpage>495</fpage>
          <lpage>499</lpage>
          <pub-id pub-id-type="doi">10.2460/ajvr.78.4.495</pub-id>
          <pub-id pub-id-type="pmid">28345992</pub-id>
        </element-citation>
      </ref>
      <ref id="B81-vaccines-11-00654">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shemesh</surname><given-names>A.A.</given-names></name>
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Limitations of the Standard Agglutination Test for Detecting Patients with <italic toggle="yes">Brucella melitensis Bacteremia</italic></article-title>
          <source>Vector-Borne Zoonotic Dis.</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>1599</fpage>
          <lpage>1601</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2011.0704</pub-id>
          <pub-id pub-id-type="pmid">21919731</pub-id>
        </element-citation>
      </ref>
      <ref id="B82-vaccines-11-00654">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fatollahzadeh</surname><given-names>B.</given-names></name>
<name><surname>Maleknejad</surname><given-names>P.</given-names></name>
<name><surname>Hejazi</surname><given-names>M.</given-names></name>
<name><surname>Pyri</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Development and evaluation of TUMS medium, a novel biphasic culture medium for isolation of <italic toggle="yes">Brucella</italic> spp. from patients</article-title>
          <source>Iran. J. Microbiol.</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>21</fpage>
          <lpage>25</lpage>
        </element-citation>
      </ref>
      <ref id="B83-vaccines-11-00654">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sagi</surname><given-names>M.</given-names></name>
<name><surname>Nesher</surname><given-names>L.</given-names></name>
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>The Bactec FX Blood Culture System Detects <italic toggle="yes">Brucella melitensis Bacteremia</italic> in Adult Patients within the Routine 1-Week Incubation Period</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2017</year>
          <volume>55</volume>
          <fpage>942</fpage>
          <lpage>946</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.02320-16</pub-id>
          <pub-id pub-id-type="pmid">28053214</pub-id>
        </element-citation>
      </ref>
      <ref id="B84-vaccines-11-00654">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baron</surname><given-names>E.J.</given-names></name>
<name><surname>Dunne</surname><given-names>M.</given-names></name>
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
<name><surname>Welch</surname><given-names>D.F.</given-names></name>
<name><surname>Wilson</surname><given-names>D.M.</given-names></name>
</person-group>
          <article-title>Cumitech 1C, blood cultures IV</article-title>
          <source>Cumitech C</source>
          <year>2005</year>
          <volume>1</volume>
          <fpage>1</fpage>
          <lpage>34</lpage>
        </element-citation>
      </ref>
      <ref id="B85-vaccines-11-00654">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>G.</given-names></name>
<name><surname>Papadimitriou</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Challenges in <italic toggle="yes">Brucella bacteraemia</italic></article-title>
          <source>Int. J. Antimicrob. Agents</source>
          <year>2007</year>
          <volume>30</volume>
          <fpage>29</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2007.06.011</pub-id>
          <pub-id pub-id-type="pmid">17706402</pub-id>
        </element-citation>
      </ref>
      <ref id="B86-vaccines-11-00654">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
<name><surname>Peled</surname><given-names>N.</given-names></name>
<name><surname>Press</surname><given-names>J.</given-names></name>
<name><surname>Abramson</surname><given-names>O.</given-names></name>
<name><surname>Abu-Rashid</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Comparison of BACTEC 9240 Peds Plus medium and isolator 1.5 microbial tube for detection of <italic toggle="yes">Brucella melitensis</italic> from blood cultures</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>1997</year>
          <volume>35</volume>
          <fpage>1382</fpage>
          <lpage>1384</lpage>
          <pub-id pub-id-type="doi">10.1128/jcm.35.6.1382-1384.1997</pub-id>
          <pub-id pub-id-type="pmid">9163448</pub-id>
        </element-citation>
      </ref>
      <ref id="B87-vaccines-11-00654">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Raj</surname><given-names>A.</given-names></name>
<name><surname>Gautam</surname><given-names>V.</given-names></name>
<name><surname>Gupta</surname><given-names>P.K.</given-names></name>
<name><surname>Sethi</surname><given-names>S.</given-names></name>
<name><surname>Rana</surname><given-names>S.</given-names></name>
<name><surname>Ray</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Rapid detection of <italic toggle="yes">Brucella</italic> by an automated blood culture system at a tertiary care hospital of north India</article-title>
          <source>Indian J. Med. Res.</source>
          <year>2014</year>
          <volume>139</volume>
          <fpage>776</fpage>
          <lpage>778</lpage>
          <pub-id pub-id-type="pmid">25027090</pub-id>
        </element-citation>
      </ref>
      <ref id="B88-vaccines-11-00654">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>F.</given-names></name>
<name><surname>Su</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Yuan</surname><given-names>X.</given-names></name>
<name><surname>Lai</surname><given-names>J.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
</person-group>
          <article-title>Sixteen Chinese pediatric brucellosis patients onset of fever in non-epidemic areas and 8 developed with osteoarticular involvement</article-title>
          <source>Clin. Rheumatol.</source>
          <year>2017</year>
          <volume>37</volume>
          <fpage>145</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1007/s10067-017-3819-y</pub-id>
          <pub-id pub-id-type="pmid">28924723</pub-id>
        </element-citation>
      </ref>
      <ref id="B89-vaccines-11-00654">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>W.J.T.</given-names></name>
</person-group>
          <article-title>Review of Techniques for the Brucellosis Laboratory; Alton, G.G., Jones, L.M., Angus, R.D., Verger, J.M., Eds.; INRA Publications: Versailles Cedex, France, 1988; p. 192</article-title>
          <source>Br. Vet. J.</source>
          <year>1990</year>
          <volume>146</volume>
          <fpage>188</fpage>
        </element-citation>
      </ref>
      <ref id="B90-vaccines-11-00654">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mesureur</surname><given-names>J.</given-names></name>
<name><surname>Arend</surname><given-names>S.</given-names></name>
<name><surname>Celli&#xE8;re</surname><given-names>B.</given-names></name>
<name><surname>Courault</surname><given-names>P.</given-names></name>
<name><surname>Cotte-Pattat</surname><given-names>P.-J.</given-names></name>
<name><surname>Totty</surname><given-names>H.</given-names></name>
<name><surname>Deol</surname><given-names>P.</given-names></name>
<name><surname>Mick</surname><given-names>V.</given-names></name>
<name><surname>Girard</surname><given-names>V.</given-names></name>
<name><surname>Touchberry</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>A MALDI-TOF MS database with broad genus coverage for species-level identification of <italic toggle="yes">Brucella</italic></article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2018</year>
          <volume>12</volume>
          <elocation-id>e0006874</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0006874</pub-id>
          <pub-id pub-id-type="pmid">30335748</pub-id>
        </element-citation>
      </ref>
      <ref id="B91-vaccines-11-00654">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Poonawala</surname><given-names>H.</given-names></name>
<name><surname>Conner</surname><given-names>T.M.</given-names></name>
<name><surname>Peaper</surname><given-names>D.R.</given-names></name>
</person-group>
          <article-title>Closing the Brief Case: Misidentification of <italic toggle="yes">Brucella melitensis</italic> as <italic toggle="yes">Ochrobactrum anthropi</italic> by Matrix-Assisted Laser Desorption Ionization&#x2013;Time of Flight Mass Spectrometry (MALDI-TOF MS)</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2018</year>
          <volume>56</volume>
          <fpage>e00914-17</fpage>
          <pub-id pub-id-type="doi">10.1128/JCM.00918-17</pub-id>
          <pub-id pub-id-type="pmid">29802238</pub-id>
        </element-citation>
      </ref>
      <ref id="B92-vaccines-11-00654">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mesureur</surname><given-names>J.</given-names></name>
<name><surname>Ranaldi</surname><given-names>S.</given-names></name>
<name><surname>Monnin</surname><given-names>V.</given-names></name>
<name><surname>Girard</surname><given-names>V.</given-names></name>
<name><surname>Arend</surname><given-names>S.</given-names></name>
<name><surname>Welker</surname><given-names>M.</given-names></name>
<name><surname>O&#x2019;Callaghan</surname><given-names>D.</given-names></name>
<name><surname>Lavigne</surname><given-names>J.-P.</given-names></name>
<name><surname>Keriel</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>A Simple and Safe Protocol for Preparing <italic toggle="yes">Brucella</italic> Samples for Matrix-Assisted Laser Desorption Ionization&#x2013;Time of Flight Mass Spectrometry Analysis</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2016</year>
          <volume>54</volume>
          <fpage>449</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.02730-15</pub-id>
          <pub-id pub-id-type="pmid">26582837</pub-id>
        </element-citation>
      </ref>
      <ref id="B93-vaccines-11-00654">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>L.</given-names></name>
<name><surname>Vega Casta&#xF1;o</surname><given-names>S.</given-names></name>
<name><surname>S&#xE1;nchez-Juanes</surname><given-names>F.</given-names></name>
<name><surname>Gonz&#xE1;lez-Cabrero</surname><given-names>S.</given-names></name>
<name><surname>Menegotto</surname><given-names>F.</given-names></name>
<name><surname>Ordu&#xF1;a-Domingo</surname><given-names>A.</given-names></name>
<name><surname>Gonz&#xE1;lez-Buitrago</surname><given-names>J.M.</given-names></name>
<name><surname>Mu&#xF1;oz-Bellido</surname><given-names>J.L.</given-names></name>
</person-group>
          <article-title>Identification of <italic toggle="yes">Brucella</italic> by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures</article-title>
          <source>PLoS ONE</source>
          <year>2010</year>
          <volume>5</volume>
          <elocation-id>e14235</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0014235</pub-id>
          <pub-id pub-id-type="pmid">21151913</pub-id>
        </element-citation>
      </ref>
      <ref id="B94-vaccines-11-00654">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Aldubaib</surname><given-names>M.</given-names></name>
<name><surname>Abalkhail</surname><given-names>A.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Albeloushi</surname><given-names>A.</given-names></name>
<name><surname>Moussa</surname><given-names>I.</given-names></name>
<name><surname>Ibrahem</surname><given-names>M.</given-names></name>
<name><surname>Albazie</surname><given-names>H.</given-names></name>
<name><surname>Alqarni</surname><given-names>A.</given-names></name>
<name><surname>Anagreyyah</surname><given-names>S.</given-names></name>
<etal/>
</person-group>
          <article-title>How MALDI-TOF Mass Spectrometry Technology Contributes to Microbial Infection Control in Healthcare Settings</article-title>
          <source>Vaccines</source>
          <year>2022</year>
          <volume>10</volume>
          <elocation-id>1881</elocation-id>
          <pub-id pub-id-type="doi">10.3390/vaccines10111881</pub-id>
          <pub-id pub-id-type="pmid">36366389</pub-id>
        </element-citation>
      </ref>
      <ref id="B95-vaccines-11-00654">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Al-Dubaib</surname><given-names>M.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Osman</surname><given-names>S.</given-names></name>
<name><surname>Edrees</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Performance of MALDI biotyper compared with Vitek&#x2122; 2 compact system for fast identification and discrimination of <italic toggle="yes">Staphylococcus</italic> species isolated from bovine mastitis</article-title>
          <source>Microbiologyopen</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>1061</fpage>
          <lpage>1070</lpage>
          <pub-id pub-id-type="doi">10.1002/mbo3.389</pub-id>
          <pub-id pub-id-type="pmid">27364641</pub-id>
        </element-citation>
      </ref>
      <ref id="B96-vaccines-11-00654">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Hamada</surname><given-names>M.</given-names></name>
<name><surname>Al-Dubaib</surname><given-names>M.</given-names></name>
<name><surname>Alyamani</surname><given-names>E.</given-names></name>
<name><surname>Moussa</surname><given-names>I.M.</given-names></name>
<name><surname>AlRowaidhan</surname><given-names>A.</given-names></name>
<name><surname>A Hemeg</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Application of MALDI-TOF MS fingerprinting as a quick tool for identification and clustering of foodborne pathogens isolated from food products</article-title>
          <source>New Microbiol.</source>
          <year>2017</year>
          <volume>40</volume>
          <fpage>269</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">28825446</pub-id>
        </element-citation>
      </ref>
      <ref id="B97-vaccines-11-00654">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Abdeen</surname><given-names>E.</given-names></name>
<name><surname>Al-Dubaib</surname><given-names>M.</given-names></name>
<name><surname>Alsayeqh</surname><given-names>A.</given-names></name>
<name><surname>Ibrahem</surname><given-names>M.</given-names></name>
<name><surname>Hamada</surname><given-names>M.</given-names></name>
<name><surname>Alenzi</surname><given-names>A.</given-names></name>
<name><surname>Moussa</surname><given-names>I.</given-names></name>
<name><surname>Hemeg</surname><given-names>H.A.</given-names></name>
</person-group>
          <article-title>Proteomic characterization and discrimination of <italic toggle="yes">Aeromonas</italic> species recovered from meat and water samples with a spotlight on the antimicrobial resistance of <italic toggle="yes">Aeromonas hydrophila</italic></article-title>
          <source>Microbiologyopen</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e782</fpage>
          <pub-id pub-id-type="doi">10.1002/mbo3.782</pub-id>
          <pub-id pub-id-type="pmid">30614207</pub-id>
        </element-citation>
      </ref>
      <ref id="B98-vaccines-11-00654">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Moussa</surname><given-names>I.M.</given-names></name>
<name><surname>Dawoud</surname><given-names>T.M.</given-names></name>
<name><surname>Mubarak</surname><given-names>A.S.</given-names></name>
<name><surname>Al-Sarar</surname><given-names>D.</given-names></name>
<name><surname>Alsubki</surname><given-names>R.A.</given-names></name>
<name><surname>Alhaji</surname><given-names>J.H.</given-names></name>
<name><surname>Hamada</surname><given-names>M.</given-names></name>
<name><surname>Abalkhail</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title><italic toggle="yes">Acinetobacter baumannii</italic> as a community foodborne pathogen: Peptide mass fingerprinting analysis, genotypic of biofilm formation and phenotypic pattern of antimicrobial resistance</article-title>
          <source>Saudi J. Biol. Sci.</source>
          <year>2020</year>
          <volume>28</volume>
          <fpage>1158</fpage>
          <lpage>1166</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sjbs.2020.11.052</pub-id>
          <pub-id pub-id-type="pmid">33424412</pub-id>
        </element-citation>
      </ref>
      <ref id="B99-vaccines-11-00654">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Elbehiry</surname><given-names>A.</given-names></name>
<name><surname>Marzouk</surname><given-names>E.</given-names></name>
<name><surname>Moussa</surname><given-names>I.M.</given-names></name>
<name><surname>Alenzi</surname><given-names>A.</given-names></name>
<name><surname>Al-Maary</surname><given-names>K.S.</given-names></name>
<name><surname>Mubarak</surname><given-names>A.S.</given-names></name>
<name><surname>Alshammari</surname><given-names>H.D.</given-names></name>
<name><surname>Al-Sarar</surname><given-names>D.</given-names></name>
<name><surname>Alsubki</surname><given-names>R.A.</given-names></name>
<name><surname>Hemeg</surname><given-names>H.A.</given-names></name>
<etal/>
</person-group>
          <article-title>Multidrug-resistant <italic toggle="yes">Escherichia coli</italic> in Raw Milk: Molecular Characterization and the potential impact of camel&#x2019;s Urine as an Antibacterial Agent</article-title>
          <source>Saudi J. Biol. Sci.</source>
          <year>2021</year>
          <volume>28</volume>
          <fpage>2091</fpage>
          <lpage>2097</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sjbs.2021.01.018</pub-id>
          <pub-id pub-id-type="pmid">33911924</pub-id>
        </element-citation>
      </ref>
      <ref id="B100-vaccines-11-00654">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sali</surname><given-names>M.</given-names></name>
<name><surname>De Maio</surname><given-names>F.</given-names></name>
<name><surname>Tarantino</surname><given-names>M.</given-names></name>
<name><surname>Garofolo</surname><given-names>G.</given-names></name>
<name><surname>Tittarelli</surname><given-names>M.</given-names></name>
<name><surname>Sacchini</surname><given-names>L.</given-names></name>
<name><surname>Zilli</surname><given-names>K.</given-names></name>
<name><surname>Pasquali</surname><given-names>P.</given-names></name>
<name><surname>Petrucci</surname><given-names>P.</given-names></name>
<name><surname>Marianelli</surname><given-names>C.</given-names></name>
<etal/>
</person-group>
          <article-title>Rapid and safe one-step extraction method for the identification of <italic toggle="yes">Brucella</italic> strains at genus and species level by MALDI-TOF mass spectrometry</article-title>
          <source>PLoS ONE</source>
          <year>2018</year>
          <volume>13</volume>
          <elocation-id>e0197864</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0197864</pub-id>
          <pub-id pub-id-type="pmid">29870530</pub-id>
        </element-citation>
      </ref>
      <ref id="B101-vaccines-11-00654">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Karger</surname><given-names>A.</given-names></name>
<name><surname>Melzer</surname><given-names>F.</given-names></name>
<name><surname>Timke</surname><given-names>M.</given-names></name>
<name><surname>Bettin</surname><given-names>B.</given-names></name>
<name><surname>Kostrzewa</surname><given-names>M.</given-names></name>
<name><surname>N&#xF6;ckler</surname><given-names>K.</given-names></name>
<name><surname>Hohmann</surname><given-names>A.</given-names></name>
<name><surname>Tomaso</surname><given-names>H.</given-names></name>
<name><surname>Neubauer</surname><given-names>H.</given-names></name>
<name><surname>Al Dahouk</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Interlaboratory Comparison of Intact-Cell Matrix-Assisted Laser Desorption Ionization&#x2013;Time of Flight Mass Spectrometry Results for Identification and Differentiation of <italic toggle="yes">Brucella</italic> spp</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2013</year>
          <volume>51</volume>
          <fpage>3123</fpage>
          <lpage>3126</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.01720-13</pub-id>
          <pub-id pub-id-type="pmid">23850950</pub-id>
        </element-citation>
      </ref>
      <ref id="B102-vaccines-11-00654">
        <label>102.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Preventing Laboratory-Acquired Brucellosis in the Era of MALDI-TOF Technology and Molecular Tests: A Narrative Review</article-title>
          <source>Zoonotic Dis.</source>
          <year>2022</year>
          <volume>2</volume>
          <fpage>172</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.3390/zoonoticdis2040016</pub-id>
        </element-citation>
      </ref>
      <ref id="B103-vaccines-11-00654">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Noviello</surname><given-names>S.</given-names></name>
<name><surname>Gallo</surname><given-names>R.</given-names></name>
<name><surname>Kelly</surname><given-names>M.</given-names></name>
<name><surname>Limberger</surname><given-names>R.J.</given-names></name>
<name><surname>DeAngelis</surname><given-names>K.</given-names></name>
<name><surname>Cain</surname><given-names>L.</given-names></name>
<name><surname>Wallace</surname><given-names>B.</given-names></name>
<name><surname>Dumas</surname><given-names>N.</given-names></name>
</person-group>
          <article-title>Laboratory-acquired brucellosis</article-title>
          <source>Emerg. Infect. Dis.</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>1848</fpage>
          <pub-id pub-id-type="doi">10.3201/eid1010.040076</pub-id>
          <pub-id pub-id-type="pmid">15504276</pub-id>
        </element-citation>
      </ref>
      <ref id="B104-vaccines-11-00654">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>E Oll&#xE9;-Goig</surname><given-names>J.</given-names></name>
<name><surname>Canela-Soler</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>An outbreak of <italic toggle="yes">Brucella melitensis</italic> infection by airborne transmission among laboratory workers</article-title>
          <source>Am. J. Public Health</source>
          <year>1987</year>
          <volume>77</volume>
          <fpage>335</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.77.3.335</pub-id>
          <pub-id pub-id-type="pmid">3812841</pub-id>
        </element-citation>
      </ref>
      <ref id="B105-vaccines-11-00654">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sophie</surname><given-names>R.</given-names></name>
<name><surname>Michael</surname><given-names>L.</given-names></name>
<name><surname>Marcel</surname><given-names>B.</given-names></name>
<name><surname>Earl</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Prevention of Laboratory-Acquired Brucellosis</article-title>
          <source>Clin. Infect. Dis.</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>e119</fpage>
          <lpage>e122</lpage>
          <pub-id pub-id-type="doi">10.1086/421024</pub-id>
          <pub-id pub-id-type="pmid">15227634</pub-id>
        </element-citation>
      </ref>
      <ref id="B106-vaccines-11-00654">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yagupsky</surname><given-names>P.</given-names></name>
<name><surname>Peled</surname><given-names>N.</given-names></name>
<name><surname>Riesenberg</surname><given-names>K.</given-names></name>
<name><surname>Banai</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area</article-title>
          <source>Scand. J. Infect. Dis.</source>
          <year>2000</year>
          <volume>32</volume>
          <fpage>31</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">10716074</pub-id>
        </element-citation>
      </ref>
      <ref id="B107-vaccines-11-00654">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Batchelor</surname><given-names>B.</given-names></name>
<name><surname>Brindle</surname><given-names>R.</given-names></name>
<name><surname>Gilks</surname><given-names>G.</given-names></name>
<name><surname>Selkon</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Biochemical mis-identification of <italic toggle="yes">Brucella melitensis</italic> and subsequent laboratory-acquired infections</article-title>
          <source>J. Hosp. Infect.</source>
          <year>1992</year>
          <volume>22</volume>
          <fpage>159</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1016/0195-6701(92)90100-Z</pub-id>
          <pub-id pub-id-type="pmid">1358958</pub-id>
        </element-citation>
      </ref>
      <ref id="B108-vaccines-11-00654">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Erg&#xF6;n&#xFC;l</surname><given-names>&#xD6;.</given-names></name>
<name><surname>Celikba&#x15F;</surname><given-names>A.</given-names></name>
<name><surname>Tezeren</surname><given-names>D.</given-names></name>
<name><surname>G&#xFC;vener</surname><given-names>E.</given-names></name>
<name><surname>Dokuzo&#x11F;uz</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Analysis of risk factors for laboratory-acquired <italic toggle="yes">Brucella</italic> infections</article-title>
          <source>J. Hosp. Infect.</source>
          <year>2004</year>
          <volume>56</volume>
          <fpage>223</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jhin.2003.12.020</pub-id>
          <pub-id pub-id-type="pmid">15003671</pub-id>
        </element-citation>
      </ref>
      <ref id="B109-vaccines-11-00654">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention</collab>
</person-group>
          <article-title>Laboratory-acquired brucellosis--Indiana and Minnesota, 2006</article-title>
          <source>MMWR Morb. Mortal. Wkly. Rep.</source>
          <year>2008</year>
          <volume>57</volume>
          <fpage>39</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">18199967</pub-id>
        </element-citation>
      </ref>
      <ref id="B110-vaccines-11-00654">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Miller</surname><given-names>J.M.</given-names></name>
<name><surname>Astles</surname><given-names>R.</given-names></name>
<name><surname>Baszler</surname><given-names>T.</given-names></name>
<name><surname>Chapin</surname><given-names>K.</given-names></name>
<name><surname>Carey</surname><given-names>R.</given-names></name>
<name><surname>Garcia</surname><given-names>L.</given-names></name>
<name><surname>Gray</surname><given-names>L.</given-names></name>
<name><surname>Larone</surname><given-names>D.</given-names></name>
<name><surname>Pentella</surname><given-names>M.</given-names></name>
<name><surname>Pollock</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title>Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel</article-title>
          <source>MMWR Suppl.</source>
          <year>2012</year>
          <volume>61</volume>
          <fpage>1</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">22217667</pub-id>
        </element-citation>
      </ref>
      <ref id="B111-vaccines-11-00654">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Abo-Shehada</surname><given-names>M.N.</given-names></name>
<name><surname>Odeh</surname><given-names>J.S.</given-names></name>
<name><surname>Abu-Essud</surname><given-names>M.</given-names></name>
<name><surname>Abuharfeil</surname><given-names>N.</given-names></name>
</person-group>
          <article-title>Seroprevalence of Brucellosis among High Risk People in Northern Jordan</article-title>
          <source>Leuk. Res.</source>
          <year>1996</year>
          <volume>25</volume>
          <fpage>450</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="doi">10.1093/ije/25.2.450</pub-id>
        </element-citation>
      </ref>
      <ref id="B112-vaccines-11-00654">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Eldin</surname><given-names>C.</given-names></name>
<name><surname>Parola</surname><given-names>P.</given-names></name>
<name><surname>Raoult</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Limitations of diagnostic tests for bacterial infections</article-title>
          <source>M&#xE9;decine Et Mal. Infect.</source>
          <year>2019</year>
          <volume>49</volume>
          <fpage>98</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1016/j.medmal.2018.12.004</pub-id>
          <pub-id pub-id-type="pmid">30686500</pub-id>
        </element-citation>
      </ref>
      <ref id="B113-vaccines-11-00654">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>D&#xED;az</surname><given-names>R.</given-names></name>
<name><surname>Casanova</surname><given-names>A.</given-names></name>
<name><surname>Ariza</surname><given-names>J.</given-names></name>
<name><surname>Moriy&#xF3;n</surname><given-names>I.</given-names></name>
</person-group>
          <article-title>The Rose Bengal Test in Human Brucellosis: A Neglected Test for the Diagnosis of a Neglected Disease</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2011</year>
          <volume>5</volume>
          <elocation-id>e950</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0000950</pub-id>
          <pub-id pub-id-type="pmid">21526218</pub-id>
        </element-citation>
      </ref>
      <ref id="B114-vaccines-11-00654">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>I Riezu-Boj</surname><given-names>J.</given-names></name>
<name><surname>Moriy&#xF3;n</surname><given-names>I.</given-names></name>
<name><surname>Blasco</surname><given-names>J.M.</given-names></name>
<name><surname>Gamazo</surname><given-names>C.</given-names></name>
<name><surname>D&#xED;az</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Antibody response to <italic toggle="yes">Brucella</italic> ovis outer membrane proteins in ovine brucellosis</article-title>
          <source>Infect. Immun.</source>
          <year>1990</year>
          <volume>58</volume>
          <fpage>489</fpage>
          <lpage>494</lpage>
          <pub-id pub-id-type="doi">10.1128/iai.58.2.489-494.1990</pub-id>
          <pub-id pub-id-type="pmid">2298488</pub-id>
        </element-citation>
      </ref>
      <ref id="B115-vaccines-11-00654">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Park</surname><given-names>S.-H.</given-names></name>
<name><surname>Lee</surname><given-names>Y.-H.</given-names></name>
<name><surname>Chu</surname><given-names>H.</given-names></name>
<name><surname>Hwang</surname><given-names>S.-D.</given-names></name>
<name><surname>Hwang</surname><given-names>K.-J.</given-names></name>
<name><surname>Choi</surname><given-names>H.-Y.</given-names></name>
<name><surname>Park</surname><given-names>M.-Y.</given-names></name>
</person-group>
          <article-title>Application of the Microagglutination Test for Serologic Diagnosis of Human Brucellosis</article-title>
          <source>Osong Public Health Res. Perspect.</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>19</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1016/j.phrp.2012.01.003</pub-id>
          <pub-id pub-id-type="pmid">24159482</pub-id>
        </element-citation>
      </ref>
      <ref id="B116-vaccines-11-00654">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Al-Marzooqi</surname><given-names>W.</given-names></name>
<name><surname>Elshafie</surname><given-names>E.I.</given-names></name>
<name><surname>Al-Toobi</surname><given-names>A.</given-names></name>
<name><surname>Al-Hamrashdi</surname><given-names>A.</given-names></name>
<name><surname>Al-Kharousi</surname><given-names>K.</given-names></name>
<name><surname>El-Tahir</surname><given-names>H.</given-names></name>
<name><surname>Jay</surname><given-names>M.</given-names></name>
<name><surname>Corde</surname><given-names>Y.</given-names></name>
<name><surname>ElTahir</surname><given-names>Y.</given-names></name>
</person-group>
          <article-title>Seroprevalence and Risk Factors of Brucellosis in Ruminants in Dhofar Province in Southern Oman</article-title>
          <source>Veter. Med. Int.</source>
          <year>2022</year>
          <volume>2022</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1155/2022/3176147</pub-id>
        </element-citation>
      </ref>
      <ref id="B117-vaccines-11-00654">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lukambagire</surname><given-names>A.S.</given-names></name>
<name><surname>Mendes</surname><given-names>J.</given-names></name>
<name><surname>Bodenham</surname><given-names>R.F.</given-names></name>
<name><surname>McGiven</surname><given-names>J.A.</given-names></name>
<name><surname>Mkenda</surname><given-names>N.A.</given-names></name>
<name><surname>Mathew</surname><given-names>C.</given-names></name>
<name><surname>Rubach</surname><given-names>M.P.</given-names></name>
<name><surname>Sakasaka</surname><given-names>P.</given-names></name>
<name><surname>Shayo</surname><given-names>D.D.</given-names></name>
<name><surname>Maro</surname><given-names>V.P.</given-names></name>
<etal/>
</person-group>
          <article-title>Performance characteristics and costs of serological tests for brucellosis in a pastoralist community of northern Tanzania</article-title>
          <source>Sci. Rep.</source>
          <year>2021</year>
          <volume>11</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1038/s41598-021-82906-w</pub-id>
          <pub-id pub-id-type="pmid">33414495</pub-id>
        </element-citation>
      </ref>
      <ref id="B118-vaccines-11-00654">
        <label>118.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Maichomo</surname><given-names>M.W.</given-names></name>
<name><surname>McDermott</surname><given-names>J.J.</given-names></name>
<name><surname>Arimi</surname><given-names>S.M.</given-names></name>
<name><surname>Gathura</surname><given-names>P.B.</given-names></name>
</person-group>
          <article-title>Assessment of the Rose-Bengal plate test for the diagnosis of human brucellosis in health facilities in Narok district, Kenya</article-title>
          <source>East Afr. Med. J.</source>
          <year>1998</year>
          <volume>75</volume>
          <fpage>219</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">9745838</pub-id>
        </element-citation>
      </ref>
      <ref id="B119-vaccines-11-00654">
        <label>119.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Saz</surname><given-names>J.V.</given-names></name>
<name><surname>Beltr&#xE1;n</surname><given-names>M.</given-names></name>
<name><surname>D&#xED;az</surname><given-names>A.</given-names></name>
<name><surname>Agulla</surname><given-names>A.</given-names></name>
<name><surname>Merino</surname><given-names>F.J.</given-names></name>
<name><surname>Villasante</surname><given-names>P.A.</given-names></name>
<name><surname>Velasco</surname><given-names>A.C.</given-names></name>
</person-group>
          <article-title>Enzyme-linked immunosorbent assay for diagnosis of brucellosis</article-title>
          <source>Eur. J. Clin. Microbiol. Infect. Dis.</source>
          <year>1987</year>
          <volume>6</volume>
          <fpage>71</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02097200</pub-id>
        </element-citation>
      </ref>
      <ref id="B120-vaccines-11-00654">
        <label>120.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Knirel</surname><given-names>Y.A.</given-names></name>
<name><surname>Perepelov</surname><given-names>A.V.</given-names></name>
<name><surname>Kondakova</surname><given-names>A.N.</given-names></name>
<name><surname>Senchenkova</surname><given-names>S.N.</given-names></name>
<name><surname>Sidorczyk</surname><given-names>Z.</given-names></name>
<name><surname>Rozalski</surname><given-names>A.</given-names></name>
<name><surname>Kaca</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Structure and serology of O-antigens as the basis for classification of <italic toggle="yes">Proteus</italic> strains</article-title>
          <source>J. Endotoxin Res.</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>70</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1177/1753425909360668</pub-id>
          <pub-id pub-id-type="pmid">20305038</pub-id>
        </element-citation>
      </ref>
      <ref id="B121-vaccines-11-00654">
        <label>121.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Imundi&#x107;</surname><given-names>A.-M.</given-names></name>
</person-group>
          <article-title>Measures of diagnostic accuracy: Basic definitions</article-title>
          <source>Ejifcc</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>203</fpage>
          <pub-id pub-id-type="pmid">27683318</pub-id>
        </element-citation>
      </ref>
      <ref id="B122-vaccines-11-00654">
        <label>122.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Al Dahouk</surname><given-names>S.</given-names></name>
<name><surname>Sprague</surname><given-names>L.</given-names></name>
<name><surname>Neubaeur</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>New developments in the diagnostic procedures for zoonotic brucellosis in humans</article-title>
          <source>Rev. Sci. Tech.</source>
          <year>2013</year>
          <volume>32</volume>
          <fpage>177</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="doi">10.20506/rst.32.1.2204</pub-id>
          <pub-id pub-id-type="pmid">23837375</pub-id>
        </element-citation>
      </ref>
      <ref id="B123-vaccines-11-00654">
        <label>123.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Abubakar</surname><given-names>M.</given-names></name>
<name><surname>Mansoor</surname><given-names>M.</given-names></name>
<name><surname>Arshed</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>Bovine Brucellosis: Old and New Concepts with Pakistan Perspective</article-title>
          <source>Pak. Vet. J.</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>147</fpage>
          <lpage>1555</lpage>
        </element-citation>
      </ref>
      <ref id="B124-vaccines-11-00654">
        <label>124.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Khurana</surname><given-names>S.K.</given-names></name>
<name><surname>Sehrawat</surname><given-names>A.</given-names></name>
<name><surname>Tiwari</surname><given-names>R.</given-names></name>
<name><surname>Prasad</surname><given-names>M.</given-names></name>
<name><surname>Gulati</surname><given-names>B.</given-names></name>
<name><surname>Shabbir</surname><given-names>M.Z.</given-names></name>
<name><surname>Chhabra</surname><given-names>R.</given-names></name>
<name><surname>Karthik</surname><given-names>K.</given-names></name>
<name><surname>Patel</surname><given-names>S.K.</given-names></name>
<name><surname>Pathak</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Bovine brucellosis&#x2014;A comprehensive review</article-title>
          <source>Vet. Q.</source>
          <year>2021</year>
          <volume>41</volume>
          <fpage>61</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1080/01652176.2020.1868616</pub-id>
          <pub-id pub-id-type="pmid">33353489</pub-id>
        </element-citation>
      </ref>
      <ref id="B125-vaccines-11-00654">
        <label>125.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lucero</surname><given-names>N.E.</given-names></name>
<name><surname>Foglia</surname><given-names>L.</given-names></name>
<name><surname>Ayala</surname><given-names>S.M.</given-names></name>
<name><surname>Gall</surname><given-names>D.</given-names></name>
<name><surname>Nielsen</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Competitive Enzyme Immunoassay for Diagnosis of Human Brucellosis</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>1999</year>
          <volume>37</volume>
          <fpage>3245</fpage>
          <lpage>3248</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.37.10.3245-3248.1999</pub-id>
          <pub-id pub-id-type="pmid">10488186</pub-id>
        </element-citation>
      </ref>
      <ref id="B126-vaccines-11-00654">
        <label>126.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Dieckhaus</surname><given-names>K.D.</given-names></name>
<name><surname>Kyebambe</surname><given-names>P.S.</given-names></name>
</person-group>
          <article-title>Human Brucellosis in Rural Uganda: Clinical Manifestations, Diagnosis, and Comorbidities at Kabale Regional Referral Hospital, Kabale, Uganda</article-title>
          <source>Open Forum Infectious Diseases</source>
          <publisher-name>Oxford University Press</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>2017</year>
          <volume>Volume 4</volume>
          <fpage>ofx237</fpage>
          <pub-id pub-id-type="doi">10.1093/ofid/ofx237</pub-id>
        </element-citation>
      </ref>
      <ref id="B127-vaccines-11-00654">
        <label>127.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Rong</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Piao</surname><given-names>D.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Tian</surname><given-names>G.</given-names></name>
<name><surname>Jiang</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Rapid detection of brucellosis using a quantum dot-based immunochromatographic test strip</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2020</year>
          <volume>14</volume>
          <elocation-id>e0008557</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0008557</pub-id>
          <pub-id pub-id-type="pmid">32976512</pub-id>
        </element-citation>
      </ref>
      <ref id="B128-vaccines-11-00654">
        <label>128.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Patra</surname><given-names>K.P.</given-names></name>
<name><surname>Saito</surname><given-names>M.</given-names></name>
<name><surname>Atluri</surname><given-names>V.L.</given-names></name>
<name><surname>Rol&#xE1;n</surname><given-names>H.G.</given-names></name>
<name><surname>Young</surname><given-names>B.</given-names></name>
<name><surname>Kerrinnes</surname><given-names>T.</given-names></name>
<name><surname>Smits</surname><given-names>H.</given-names></name>
<name><surname>Ricaldi</surname><given-names>J.N.</given-names></name>
<name><surname>Gotuzzo</surname><given-names>E.</given-names></name>
<name><surname>Gilman</surname><given-names>R.H.</given-names></name>
<etal/>
</person-group>
          <article-title>A Protein-Conjugate Approach to Develop a Monoclonal Antibody-Based Antigen Detection Test for the Diagnosis of Human Brucellosis</article-title>
          <source>PLoS Negl. Trop. Dis.</source>
          <year>2014</year>
          <volume>8</volume>
          <elocation-id>e2926</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0002926</pub-id>
          <pub-id pub-id-type="pmid">24901521</pub-id>
        </element-citation>
      </ref>
      <ref id="B129-vaccines-11-00654">
        <label>129.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zerva</surname><given-names>L.</given-names></name>
<name><surname>Bourantas</surname><given-names>K.</given-names></name>
<name><surname>Mitka</surname><given-names>S.</given-names></name>
<name><surname>Kansouzidou</surname><given-names>A.</given-names></name>
<name><surname>Legakis</surname><given-names>N.J.</given-names></name>
</person-group>
          <article-title>Serum Is the Preferred Clinical Specimen for Diagnosis of Human Brucellosis by PCR</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2001</year>
          <volume>39</volume>
          <fpage>1661</fpage>
          <lpage>1664</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.39.4.1661-1664.2001</pub-id>
          <pub-id pub-id-type="pmid">11283112</pub-id>
        </element-citation>
      </ref>
      <ref id="B130-vaccines-11-00654">
        <label>130.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hull</surname><given-names>N.C.</given-names></name>
<name><surname>Schumaker</surname><given-names>B.A.</given-names></name>
</person-group>
          <article-title>Comparisons of brucellosis between human and veterinary medicine</article-title>
          <source>Infect. Ecol. Epidemiol.</source>
          <year>2018</year>
          <volume>8</volume>
          <fpage>1500846</fpage>
          <pub-id pub-id-type="doi">10.1080/20008686.2018.1500846</pub-id>
          <pub-id pub-id-type="pmid">30083304</pub-id>
        </element-citation>
      </ref>
      <ref id="B131-vaccines-11-00654">
        <label>131.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Buzgan</surname><given-names>T.</given-names></name>
<name><surname>Karahocagil</surname><given-names>M.K.</given-names></name>
<name><surname>Irmak</surname><given-names>H.</given-names></name>
<name><surname>Baran</surname><given-names>A.I.</given-names></name>
<name><surname>Karsen</surname><given-names>H.</given-names></name>
<name><surname>Evirgen</surname><given-names>O.</given-names></name>
<name><surname>Akdeniz</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature</article-title>
          <source>Int. J. Infect. Dis.</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>e469</fpage>
          <lpage>e478</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijid.2009.06.031</pub-id>
          <pub-id pub-id-type="pmid">19910232</pub-id>
        </element-citation>
      </ref>
      <ref id="B132-vaccines-11-00654">
        <label>132.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Manivannan</surname><given-names>K.</given-names></name>
<name><surname>Mahmoud</surname><given-names>S.M.</given-names></name>
<name><surname>Ramasamy</surname><given-names>M.</given-names></name>
<name><surname>Shehata</surname><given-names>A.A.</given-names></name>
<name><surname>Ahmed</surname><given-names>H.</given-names></name>
<name><surname>Solaimuthu</surname><given-names>C.</given-names></name>
<name><surname>Dhandapani</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Molecular detection of brucellosis in dromedary camels of Qatar by real-time PCR technique</article-title>
          <source>Comp. Immunol. Microbiol. Infect. Dis.</source>
          <year>2021</year>
          <volume>78</volume>
          <fpage>101690</fpage>
          <pub-id pub-id-type="doi">10.1016/j.cimid.2021.101690</pub-id>
          <pub-id pub-id-type="pmid">34265544</pub-id>
        </element-citation>
      </ref>
      <ref id="B133-vaccines-11-00654">
        <label>133.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Steinau</surname><given-names>M.</given-names></name>
<name><surname>Patel</surname><given-names>S.S.</given-names></name>
<name><surname>Unger</surname><given-names>E.R.</given-names></name>
</person-group>
          <article-title>Efficient DNA Extraction for HPV Genotyping in Formalin-Fixed, Paraffin-Embedded Tissues</article-title>
          <source>J. Mol. Diagn.</source>
          <year>2011</year>
          <volume>13</volume>
          <fpage>377</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmoldx.2011.03.007</pub-id>
          <pub-id pub-id-type="pmid">21704270</pub-id>
        </element-citation>
      </ref>
      <ref id="B134-vaccines-11-00654">
        <label>134.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Becker</surname><given-names>G.N.</given-names></name>
<name><surname>Tuon</surname><given-names>F.F.</given-names></name>
</person-group>
          <article-title>Comparative study of IS711 and bcsp31-based polymerase chain reaction (PCR) for the diagnosis of human brucellosis in whole blood and serum samples</article-title>
          <source>J. Microbiol. Methods</source>
          <year>2021</year>
          <volume>183</volume>
          <fpage>106182</fpage>
          <pub-id pub-id-type="doi">10.1016/j.mimet.2021.106182</pub-id>
          <pub-id pub-id-type="pmid">33647359</pub-id>
        </element-citation>
      </ref>
      <ref id="B135-vaccines-11-00654">
        <label>135.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kattar</surname><given-names>M.M.</given-names></name>
<name><surname>Zalloua</surname><given-names>P.A.</given-names></name>
<name><surname>Araj</surname><given-names>G.F.</given-names></name>
<name><surname>Samaha-Kfoury</surname><given-names>J.</given-names></name>
<name><surname>Shbaklo</surname><given-names>H.</given-names></name>
<name><surname>Kanj</surname><given-names>S.</given-names></name>
<name><surname>Khalife</surname><given-names>S.</given-names></name>
<name><surname>Deeb</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Development and evaluation of real-time polymerase chain reaction assays on whole blood and paraffin-embedded tissues for rapid diagnosis of human brucellosis</article-title>
          <source>Diagn. Microbiol. Infect. Dis.</source>
          <year>2007</year>
          <volume>59</volume>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2007.04.002</pub-id>
          <pub-id pub-id-type="pmid">17532591</pub-id>
        </element-citation>
      </ref>
      <ref id="B136-vaccines-11-00654">
        <label>136.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baddour</surname><given-names>M.M.</given-names></name>
<name><surname>Alkhalifa</surname><given-names>D.H.</given-names></name>
</person-group>
          <article-title>Evaluation of three polymerase chain reaction techniques for detection of <italic toggle="yes">Brucella</italic> DNA in peripheral human blood</article-title>
          <source>Can. J. Microbiol.</source>
          <year>2008</year>
          <volume>54</volume>
          <fpage>352</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1139/W08-017</pub-id>
          <pub-id pub-id-type="pmid">18449219</pub-id>
        </element-citation>
      </ref>
      <ref id="B137-vaccines-11-00654">
        <label>137.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bounaadja</surname><given-names>L.</given-names></name>
<name><surname>Albert</surname><given-names>D.</given-names></name>
<name><surname>Ch&#xE9;nais</surname><given-names>B.</given-names></name>
<name><surname>H&#xE9;nault</surname><given-names>S.</given-names></name>
<name><surname>Zygmunt</surname><given-names>M.S.</given-names></name>
<name><surname>Poliak</surname><given-names>S.</given-names></name>
<name><surname>Garin-Bastuji</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Real-time PCR for identification of <italic toggle="yes">Brucella</italic> spp.: A comparative study of IS711, bcsp31 and per target genes</article-title>
          <source>Veter. Microbiol.</source>
          <year>2009</year>
          <volume>137</volume>
          <fpage>156</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vetmic.2008.12.023</pub-id>
        </element-citation>
      </ref>
      <ref id="B138-vaccines-11-00654">
        <label>138.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Navarro</surname><given-names>E.</given-names></name>
<name><surname>Serrano-Heras</surname><given-names>G.</given-names></name>
<name><surname>Casta&#xF1;o</surname><given-names>M.</given-names></name>
<name><surname>Solera</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Real-time PCR detection chemistry</article-title>
          <source>Clin. Chim. Acta</source>
          <year>2015</year>
          <volume>439</volume>
          <fpage>231</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cca.2014.10.017</pub-id>
          <pub-id pub-id-type="pmid">25451956</pub-id>
        </element-citation>
      </ref>
      <ref id="B139-vaccines-11-00654">
        <label>139.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Garc&#xED;a-Yoldi</surname><given-names>D.</given-names></name>
<name><surname>Mar&#xED;n</surname><given-names>C.M.</given-names></name>
<name><surname>De Miguel</surname><given-names>M.J.</given-names></name>
<name><surname>Mu&#xF1;oz</surname><given-names>P.M.</given-names></name>
<name><surname>Vizmanos</surname><given-names>J.L.</given-names></name>
<name><surname>L&#xF3;pez-Go&#xF1;i</surname><given-names>I.</given-names></name>
</person-group>
          <article-title>Multiplex PCR Assay for the Identification and Differentiation of all <italic toggle="yes">Brucella</italic> Species and the Vaccine Strains <italic toggle="yes">Brucella</italic> abortus S19 and RB51 and <italic toggle="yes">Brucella melitensis</italic> Rev1</article-title>
          <source>Clin. Chem.</source>
          <year>2006</year>
          <volume>52</volume>
          <fpage>779</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="doi">10.1373/clinchem.2005.062596</pub-id>
          <pub-id pub-id-type="pmid">16595839</pub-id>
        </element-citation>
      </ref>
      <ref id="B140-vaccines-11-00654">
        <label>140.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lopez-Go&#xF1;i</surname><given-names>I.</given-names></name>
<name><surname>Garcia-Yoldi</surname><given-names>D.</given-names></name>
<name><surname>Mar&#xED;n</surname><given-names>C.</given-names></name>
<name><surname>De Miguel</surname><given-names>M.</given-names></name>
<name><surname>Munoz</surname><given-names>P.</given-names></name>
<name><surname>Blasco</surname><given-names>J.</given-names></name>
<name><surname>Jacques</surname><given-names>I.</given-names></name>
<name><surname>Grayon</surname><given-names>M.</given-names></name>
<name><surname>Cloeckaert</surname><given-names>A.</given-names></name>
<name><surname>Ferreira</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all <italic toggle="yes">Brucella</italic> species, including the vaccine strains</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>3484</fpage>
          <lpage>3487</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.00837-08</pub-id>
          <pub-id pub-id-type="pmid">18716225</pub-id>
        </element-citation>
      </ref>
      <ref id="B141-vaccines-11-00654">
        <label>141.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>L&#xF3;pez-Go&#xF1;i</surname><given-names>I.</given-names></name>
<name><surname>Garc&#xED;a-Yoldi</surname><given-names>D.</given-names></name>
<name><surname>Mar&#xED;n</surname><given-names>C.M.</given-names></name>
<name><surname>de Miguel</surname><given-names>M.J.</given-names></name>
<name><surname>Barquero-Calvo</surname><given-names>E.</given-names></name>
<name><surname>Guzm&#xE1;n-Verri</surname><given-names>C.</given-names></name>
<name><surname>Albert</surname><given-names>D.</given-names></name>
<name><surname>Garin-Bastuji</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>New Bruce-ladder multiplex PCR assay for the biovar typing of <italic toggle="yes">Brucella suis</italic> and the discrimination of <italic toggle="yes">Brucella suis</italic> and <italic toggle="yes">Brucella canis</italic></article-title>
          <source>Veter. Microbiol.</source>
          <year>2011</year>
          <volume>154</volume>
          <fpage>152</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vetmic.2011.06.035</pub-id>
          <pub-id pub-id-type="pmid">21782356</pub-id>
        </element-citation>
      </ref>
      <ref id="B142-vaccines-11-00654">
        <label>142.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<collab>OIE</collab>
</person-group>
          <article-title>Chapter 2.4.3. Bovine brucellosis</article-title>
          <source>Manual of Diagnostic Tests and Vaccines for Terrestrial Animals</source>
          <publisher-name>Office International Des &#xC9;pizootie</publisher-name>
          <publisher-loc>Paris, France</publisher-loc>
          <year>2009</year>
          <fpage>564</fpage>
          <lpage>567</lpage>
        </element-citation>
      </ref>
      <ref id="B143-vaccines-11-00654">
        <label>143.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Moeini-Zanjani</surname><given-names>A.</given-names></name>
<name><surname>Pournajaf</surname><given-names>A.</given-names></name>
<name><surname>Ferdosi-Shahandashti</surname><given-names>E.</given-names></name>
<name><surname>Gholami</surname><given-names>M.</given-names></name>
<name><surname>Masjedian</surname><given-names>F.</given-names></name>
<name><surname>Khafri</surname><given-names>S.</given-names></name>
<name><surname>Rajabnia</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Comparison of loop-mediated isothermal amplification and conventional PCR tests for diagnosis of common <italic toggle="yes">Brucella</italic> species</article-title>
          <source>BMC Res. Notes</source>
          <year>2020</year>
          <volume>13</volume>
          <elocation-id>533</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s13104-020-05377-8</pub-id>
          <pub-id pub-id-type="pmid">33187548</pub-id>
        </element-citation>
      </ref>
      <ref id="B144-vaccines-11-00654">
        <label>144.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Notomi</surname><given-names>T.</given-names></name>
<name><surname>Okayama</surname><given-names>H.</given-names></name>
<name><surname>Masubuchi</surname><given-names>H.</given-names></name>
<name><surname>Yonekawa</surname><given-names>T.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
<name><surname>Amino</surname><given-names>N.</given-names></name>
<name><surname>Hase</surname><given-names>T.</given-names></name>
</person-group>
          <article-title>Loop-mediated isothermal amplification of DNA</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>e63</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/28.12.e63</pub-id>
          <pub-id pub-id-type="pmid">10871386</pub-id>
        </element-citation>
      </ref>
      <ref id="B145-vaccines-11-00654">
        <label>145.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Soroka</surname><given-names>M.</given-names></name>
<name><surname>Wasowicz</surname><given-names>B.</given-names></name>
<name><surname>Rymaszewska</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Loop-mediated isothermal amplification (LAMP): The better sibling of PCR?</article-title>
          <source>Cells</source>
          <year>2021</year>
          <volume>10</volume>
          <elocation-id>1931</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cells10081931</pub-id>
          <pub-id pub-id-type="pmid">34440699</pub-id>
        </element-citation>
      </ref>
      <ref id="B146-vaccines-11-00654">
        <label>146.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nimri</surname><given-names>L.F.</given-names></name>
</person-group>
          <article-title>Diagnosis of recent and relapsed cases of human brucellosis by PCR assay</article-title>
          <source>BMC Infect. Dis.</source>
          <year>2003</year>
          <volume>3</volume>
          <elocation-id>5</elocation-id>
          <pub-id pub-id-type="doi">10.1186/1471-2334-3-5</pub-id>
          <pub-id pub-id-type="pmid">12718759</pub-id>
        </element-citation>
      </ref>
      <ref id="B147-vaccines-11-00654">
        <label>147.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Surucuoglu</surname><given-names>S.</given-names></name>
<name><surname>El</surname><given-names>S.</given-names></name>
<name><surname>Ural</surname><given-names>S.</given-names></name>
<name><surname>Gazi</surname><given-names>H.</given-names></name>
<name><surname>Kurutepe</surname><given-names>S.</given-names></name>
<name><surname>Taskiran</surname><given-names>P.</given-names></name>
<name><surname>Yurtsever</surname><given-names>S.G.</given-names></name>
</person-group>
          <article-title>Evaluation of real-time PCR method for rapid diagnosis of brucellosis with different clinical manifestations</article-title>
          <source>Pol. J. Microbiol.</source>
          <year>2009</year>
          <volume>58</volume>
          <fpage>15</fpage>
          <pub-id pub-id-type="pmid">19469281</pub-id>
        </element-citation>
      </ref>
      <ref id="B148-vaccines-11-00654">
        <label>148.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Halling</surname><given-names>S.M.</given-names></name>
<name><surname>Peterson-Burch</surname><given-names>B.D.</given-names></name>
<name><surname>Bricker</surname><given-names>B.J.</given-names></name>
<name><surname>Zuerner</surname><given-names>R.L.</given-names></name>
<name><surname>Qing</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>L.-L.</given-names></name>
<name><surname>Kapur</surname><given-names>V.</given-names></name>
<name><surname>Alt</surname><given-names>D.P.</given-names></name>
<name><surname>Olsen</surname><given-names>S.C.</given-names></name>
</person-group>
          <article-title>Completion of the Genome Sequence of <italic toggle="yes">Brucella abortus</italic> and Comparison to the Highly Similar Genomes of <italic toggle="yes">Brucella melitensis</italic> and <italic toggle="yes">Brucella suis</italic></article-title>
          <source>J. Bacteriol.</source>
          <year>2005</year>
          <volume>187</volume>
          <fpage>2715</fpage>
          <lpage>2726</lpage>
          <pub-id pub-id-type="doi">10.1128/JB.187.8.2715-2726.2005</pub-id>
          <pub-id pub-id-type="pmid">15805518</pub-id>
        </element-citation>
      </ref>
      <ref id="B149-vaccines-11-00654">
        <label>149.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Eko</surname><given-names>S.M.</given-names></name>
<name><surname>Esemu</surname><given-names>S.N.</given-names></name>
<name><surname>Nota</surname><given-names>A.D.</given-names></name>
<name><surname>Ndip</surname><given-names>L.M.</given-names></name>
</person-group>
          <article-title>A Review on Brucellosis in Cameroon: Diagnostic Approaches, Epidemiology and Risk Factors for Infection</article-title>
          <source>Adv. Microbiol.</source>
          <year>2022</year>
          <volume>12</volume>
          <fpage>415</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="doi">10.4236/aim.2022.127030</pub-id>
        </element-citation>
      </ref>
      <ref id="B150-vaccines-11-00654">
        <label>150.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Islam</surname><given-names>M.S.</given-names></name>
<name><surname>El Zowalaty</surname><given-names>M.E.</given-names></name>
<name><surname>van Vliet</surname><given-names>A.H.</given-names></name>
<name><surname>Thakur</surname><given-names>S.</given-names></name>
<name><surname>Khatun</surname><given-names>M.M.</given-names></name>
<name><surname>Saha</surname><given-names>S.</given-names></name>
<name><surname>Rahman</surname><given-names>M.T.</given-names></name>
<name><surname>Noreddin</surname><given-names>A.</given-names></name>
<name><surname>Islam</surname><given-names>M.A.</given-names></name>
</person-group>
          <article-title>First genome sequence of <italic toggle="yes">Brucella abortus</italic> biovar 3 strain BAU21/S4023, isolated from a dairy cow in Bangladesh</article-title>
          <source>Microbiol. Resour. Announc.</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e00446-19</fpage>
          <pub-id pub-id-type="doi">10.1128/MRA.00446-19</pub-id>
          <pub-id pub-id-type="pmid">31196923</pub-id>
        </element-citation>
      </ref>
      <ref id="B151-vaccines-11-00654">
        <label>151.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Etemadi</surname><given-names>A.</given-names></name>
<name><surname>Moniri</surname><given-names>R.</given-names></name>
<name><surname>Neubauer</surname><given-names>H.</given-names></name>
<name><surname>Goli</surname><given-names>Y.D.</given-names></name>
<name><surname>Alamian</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Laboratory Diagnostic Procedures for Human Brucellosis: An Overview of Existing Approaches</article-title>
          <source>Jundishapur J. Microbiol.</source>
          <year>2019</year>
          <comment>
<italic toggle="yes">in press</italic>
</comment>
          <pub-id pub-id-type="doi">10.5812/jjm.91200</pub-id>
        </element-citation>
      </ref>
      <ref id="B152-vaccines-11-00654">
        <label>152.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Tian</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Gao</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
</person-group>
          <article-title>A systematic analysis of and recommendations for public health events involving brucellosis from 2006 to 2019 in China</article-title>
          <source>Ann. Med.</source>
          <year>2022</year>
          <volume>54</volume>
          <fpage>1859</fpage>
          <lpage>1866</lpage>
          <pub-id pub-id-type="doi">10.1080/07853890.2022.2092894</pub-id>
          <pub-id pub-id-type="pmid">35786155</pub-id>
        </element-citation>
      </ref>
      <ref id="B153-vaccines-11-00654">
        <label>153.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Schurig</surname><given-names>G.G.</given-names></name>
<name><surname>Sriranganathan</surname><given-names>N.</given-names></name>
<name><surname>Corbel</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>Brucellosis vaccines: Past, present and future</article-title>
          <source>Vet. Microbiol.</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>479</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00255-9</pub-id>
          <pub-id pub-id-type="pmid">12414166</pub-id>
        </element-citation>
      </ref>
      <ref id="B154-vaccines-11-00654">
        <label>154.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Jiang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Ding</surname><given-names>J.</given-names></name>
<name><surname>Suo</surname><given-names>X.</given-names></name>
</person-group>
          <article-title><italic toggle="yes">Brucella suis</italic> strain 2 vaccine is safe and protective against heterologous <italic toggle="yes">Brucella</italic> spp. infections</article-title>
          <source>Vaccine</source>
          <year>2016</year>
          <volume>34</volume>
          <fpage>395</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.09.116</pub-id>
          <pub-id pub-id-type="pmid">26626213</pub-id>
        </element-citation>
      </ref>
      <ref id="B155-vaccines-11-00654">
        <label>155.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hou</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Peng</surname><given-names>Q.</given-names></name>
</person-group>
          <article-title>The advances in brucellosis vaccines</article-title>
          <source>Vaccine</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>3981</fpage>
          <lpage>3988</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.05.084</pub-id>
          <pub-id pub-id-type="pmid">31176541</pub-id>
        </element-citation>
      </ref>
      <ref id="B156-vaccines-11-00654">
        <label>156.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Perkins</surname><given-names>S.D.</given-names></name>
<name><surname>Smither</surname><given-names>S.J.</given-names></name>
<name><surname>Atkins</surname><given-names>H.S.</given-names></name>
</person-group>
          <article-title>Towards a <italic toggle="yes">Brucella</italic> vaccine for humans</article-title>
          <source>FEMS Microbiol. Rev.</source>
          <year>2010</year>
          <volume>34</volume>
          <fpage>379</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1574-6976.2010.00211.x</pub-id>
          <pub-id pub-id-type="pmid">20180858</pub-id>
        </element-citation>
      </ref>
      <ref id="B157-vaccines-11-00654">
        <label>157.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Darbandi</surname><given-names>A.</given-names></name>
<name><surname>Alamdary</surname><given-names>S.Z.</given-names></name>
<name><surname>Koupaei</surname><given-names>M.</given-names></name>
<name><surname>Ghanavati</surname><given-names>R.</given-names></name>
<name><surname>Heidary</surname><given-names>M.</given-names></name>
<name><surname>Talebi</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Evaluation of immune responses to <italic toggle="yes">Brucella</italic> vaccines in mouse models: A systematic review</article-title>
          <source>Front. Veter. Sci.</source>
          <year>2022</year>
          <volume>9</volume>
          <fpage>1287</fpage>
          <pub-id pub-id-type="doi">10.3389/fvets.2022.903890</pub-id>
          <pub-id pub-id-type="pmid">36118342</pub-id>
        </element-citation>
      </ref>
      <ref id="B158-vaccines-11-00654">
        <label>158.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nicoletti</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>The control of brucellosis in tropical and subtropical regions</article-title>
          <source>Prev. Veter. Med.</source>
          <year>1984</year>
          <volume>2</volume>
          <fpage>193</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="doi">10.1016/0167-5877(84)90062-X</pub-id>
        </element-citation>
      </ref>
      <ref id="B159-vaccines-11-00654">
        <label>159.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Godfroid</surname><given-names>J.</given-names></name>
<name><surname>Nielsen</surname><given-names>K.</given-names></name>
<name><surname>Saegerman</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Diagnosis of Brucellosis in Livestock and Wildlife</article-title>
          <source>Croat. Med. J.</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>296</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="doi">10.3325/cmj.2010.51.296</pub-id>
          <pub-id pub-id-type="pmid">20718082</pub-id>
        </element-citation>
      </ref>
      <ref id="B160-vaccines-11-00654">
        <label>160.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Godfroid</surname><given-names>J.</given-names></name>
<name><surname>Scholz</surname><given-names>H.</given-names></name>
<name><surname>Barbier</surname><given-names>T.</given-names></name>
<name><surname>Nicolas</surname><given-names>C.</given-names></name>
<name><surname>Wattiau</surname><given-names>P.</given-names></name>
<name><surname>Fretin</surname><given-names>D.</given-names></name>
<name><surname>Whatmore</surname><given-names>A.</given-names></name>
<name><surname>Cloeckaert</surname><given-names>A.</given-names></name>
<name><surname>Blasco</surname><given-names>J.</given-names></name>
<name><surname>Moriyon</surname><given-names>I.</given-names></name>
<etal/>
</person-group>
          <article-title>Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century</article-title>
          <source>Prev. Veter. Med.</source>
          <year>2011</year>
          <volume>102</volume>
          <fpage>118</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prevetmed.2011.04.007</pub-id>
        </element-citation>
      </ref>
      <ref id="B161-vaccines-11-00654">
        <label>161.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>McDermott</surname><given-names>J.J.</given-names></name>
<name><surname>Arimi</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Brucellosis in sub-Saharan Africa: Epidemiology, control and impact</article-title>
          <source>Veter. Microbiol.</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>111</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00249-3</pub-id>
        </element-citation>
      </ref>
      <ref id="B162-vaccines-11-00654">
        <label>162.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Muma</surname><given-names>J.</given-names></name>
<name><surname>Samui</surname><given-names>K.</given-names></name>
<name><surname>Oloya</surname><given-names>J.</given-names></name>
<name><surname>Munyeme</surname><given-names>M.</given-names></name>
<name><surname>Skjerve</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Risk factors for brucellosis in indigenous cattle reared in livestock&#x2013;wildlife interface areas of Zambia</article-title>
          <source>Prev. Veter. Med.</source>
          <year>2007</year>
          <volume>80</volume>
          <fpage>306</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prevetmed.2007.03.003</pub-id>
          <pub-id pub-id-type="pmid">17481753</pub-id>
        </element-citation>
      </ref>
      <ref id="B163-vaccines-11-00654">
        <label>163.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Blasco</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Existing and future vaccines against brucellosis in small ruminants</article-title>
          <source>Small Rumin. Res.</source>
          <year>2006</year>
          <volume>62</volume>
          <fpage>33</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.1016/j.smallrumres.2005.07.034</pub-id>
        </element-citation>
      </ref>
      <ref id="B164-vaccines-11-00654">
        <label>164.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Palmer</surname><given-names>M.V.</given-names></name>
<name><surname>Olsen</surname><given-names>S.C.</given-names></name>
<name><surname>Cheville</surname><given-names>N.F.</given-names></name>
</person-group>
          <article-title>Safety and immunogenicity of <italic toggle="yes">Brucella abortus</italic> strain RB51 vaccine in pregnant cattle</article-title>
          <source>Am. J. Veter. Res.</source>
          <year>1997</year>
          <volume>58</volume>
          <fpage>472</fpage>
          <lpage>477</lpage>
        </element-citation>
      </ref>
      <ref id="B165-vaccines-11-00654">
        <label>165.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Salmakov</surname><given-names>K.</given-names></name>
<name><surname>Abdullin</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Testing of <italic toggle="yes">Brucella</italic> strain 82 as a live vaccine under experimental and practical conditions</article-title>
          <source>Res. Pap. Kazan State Vet. Inst.</source>
          <year>1965</year>
          <volume>96</volume>
          <fpage>38</fpage>
          <lpage>45</lpage>
        </element-citation>
      </ref>
      <ref id="B166-vaccines-11-00654">
        <label>166.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nikiforov</surname><given-names>I.</given-names></name>
<name><surname>Razumovskaya</surname><given-names>V.</given-names></name>
<name><surname>Bokova</surname><given-names>T.</given-names></name>
<name><surname>Stepanov</surname><given-names>V.</given-names></name>
<name><surname>Korzh</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Study of the optimal immunizing dose of the brucellosis vaccine from strain B; abortus 75/79-AB</article-title>
          <source>J. Vet.</source>
          <year>1995</year>
          <volume>12</volume>
          <fpage>29</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="B167-vaccines-11-00654">
        <label>167.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Nikiforov</surname><given-names>I.</given-names></name>
<name><surname>Shumilov</surname><given-names>K.</given-names></name>
<name><surname>Klimanov</surname><given-names>A.</given-names></name>
<name><surname>Shikhaleev YuN</surname><given-names>K.V.</given-names></name>
<name><surname>Solntseva</surname><given-names>E.J.</given-names></name>
</person-group>
          <article-title>Study of the adaptability, virulence, and possible migration of strain B. abortus 75/79-AV</article-title>
          <source>Collection of Scientific Works of the Institute of Experimental Veterinary Science of Siberia and the Far East</source>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Novosibirsk, Russia</publisher-loc>
          <year>1993</year>
          <volume>Volume 12</volume>
          <fpage>66</fpage>
          <lpage>73</lpage>
        </element-citation>
      </ref>
      <ref id="B168-vaccines-11-00654">
        <label>168.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shumilov</surname><given-names>K.V.</given-names></name>
<name><surname>Sklyarov</surname><given-names>O.</given-names></name>
<name><surname>Klimanov</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Designing vaccines against cattle brucellosis</article-title>
          <source>Vaccine</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>F31</fpage>
          <lpage>F34</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.03.049</pub-id>
          <pub-id pub-id-type="pmid">20362619</pub-id>
        </element-citation>
      </ref>
      <ref id="B169-vaccines-11-00654">
        <label>169.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mu</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Yan</surname><given-names>X.</given-names></name>
<name><surname>Mao</surname><given-names>X.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Qin</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Detection of <italic toggle="yes">Brucella</italic> S2 vaccine strain by a loop-mediated isothermal amplification (LAMP) method</article-title>
          <source>Front. Cell. Infect. Microbiol.</source>
          <year>2022</year>
          <volume>12</volume>
          <fpage>1780</fpage>
          <pub-id pub-id-type="doi">10.3389/fcimb.2022.1023243</pub-id>
        </element-citation>
      </ref>
      <ref id="B170-vaccines-11-00654">
        <label>170.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Moreno</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Retrospective and prospective perspectives on zoonotic brucellosis</article-title>
          <source>Front. Microbiol.</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>213</fpage>
          <pub-id pub-id-type="doi">10.3389/fmicb.2014.00213</pub-id>
          <pub-id pub-id-type="pmid">24860561</pub-id>
        </element-citation>
      </ref>
      <ref id="B171-vaccines-11-00654">
        <label>171.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Herrera-L&#xF3;pez</surname><given-names>E.</given-names></name>
<name><surname>Su&#xE1;rez-G&#xFC;emes</surname><given-names>F.</given-names></name>
<name><surname>Hern&#xE1;ndez-Andrade</surname><given-names>L.</given-names></name>
<name><surname>C&#xF3;rdova-L&#xF3;pez</surname><given-names>D.</given-names></name>
<name><surname>D&#xED;az-Aparicio</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Epidemiological study of Brucellosis in cattle, immunized with <italic toggle="yes">Brucella abortus</italic> RB51 vaccine in endemic zones</article-title>
          <source>Vaccine</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>F59</fpage>
          <lpage>F63</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.03.057</pub-id>
          <pub-id pub-id-type="pmid">20362623</pub-id>
        </element-citation>
      </ref>
      <ref id="B172-vaccines-11-00654">
        <label>172.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Whatmore</surname><given-names>A.M.</given-names></name>
</person-group>
          <article-title>Current understanding of the genetic diversity of <italic toggle="yes">Brucella</italic>, an expanding genus of zoonotic pathogens</article-title>
          <source>Infect. Genet. Evol.</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>1168</fpage>
          <lpage>1184</lpage>
          <pub-id pub-id-type="doi">10.1016/j.meegid.2009.07.001</pub-id>
          <pub-id pub-id-type="pmid">19628055</pub-id>
        </element-citation>
      </ref>
      <ref id="B173-vaccines-11-00654">
        <label>173.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Rajasekaran</surname><given-names>P.</given-names></name>
<name><surname>Surendran</surname><given-names>N.</given-names></name>
<name><surname>Seleem</surname><given-names>M.N.</given-names></name>
<name><surname>Sriranganathan</surname><given-names>N.</given-names></name>
<name><surname>Schurig</surname><given-names>G.G.</given-names></name>
<name><surname>Boyle</surname><given-names>S.M.</given-names></name>
</person-group>
          <article-title>Over-expression of homologous antigens in a leucine auxotroph of <italic toggle="yes">Brucella abortus</italic> strain RB51 protects mice against a virulent <italic toggle="yes">B. suis</italic> challenge</article-title>
          <source>Vaccine</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>3106</fpage>
          <lpage>3110</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.02.054</pub-id>
          <pub-id pub-id-type="pmid">21376799</pub-id>
        </element-citation>
      </ref>
      <ref id="B174-vaccines-11-00654">
        <label>174.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Luo</surname><given-names>D.</given-names></name>
<name><surname>Xing</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Duan</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>P.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
</person-group>
          <article-title>Protection of mice from <italic toggle="yes">Brucella</italic> infection by immunization with attenuated <italic toggle="yes">Salmonellaenterica</italic> serovar typhimurium expressing A L7/L12 and BLS fusion antigen of <italic toggle="yes">Brucella</italic></article-title>
          <source>Vaccine</source>
          <year>2009</year>
          <volume>27</volume>
          <fpage>5214</fpage>
          <lpage>5219</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.06.075</pub-id>
          <pub-id pub-id-type="pmid">19596411</pub-id>
        </element-citation>
      </ref>
      <ref id="B175-vaccines-11-00654">
        <label>175.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pasquevich</surname><given-names>K.A.</given-names></name>
<name><surname>Iba&#xF1;ez</surname><given-names>A.E.</given-names></name>
<name><surname>Coria</surname><given-names>L.M.</given-names></name>
<name><surname>Samartino</surname><given-names>C.G.</given-names></name>
<name><surname>Estein</surname><given-names>S.M.</given-names></name>
<name><surname>Zwerdling</surname><given-names>A.</given-names></name>
<name><surname>Barrionuevo</surname><given-names>P.</given-names></name>
<name><surname>Oliveira</surname><given-names>F.S.</given-names></name>
<name><surname>Seither</surname><given-names>C.</given-names></name>
<name><surname>Warzecha</surname><given-names>H.</given-names></name>
<etal/>
</person-group>
          <article-title>An Oral Vaccine Based on U-Omp19 Induces Protection against <italic toggle="yes">B. abortus</italic> Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice</article-title>
          <source>PLoS ONE</source>
          <year>2011</year>
          <volume>6</volume>
          <elocation-id>e16203</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0016203</pub-id>
          <pub-id pub-id-type="pmid">21264260</pub-id>
        </element-citation>
      </ref>
      <ref id="B176-vaccines-11-00654">
        <label>176.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>G&#xF3;mez</surname><given-names>L.</given-names></name>
<name><surname>Llanos</surname><given-names>J.</given-names></name>
<name><surname>Escalona</surname><given-names>E.</given-names></name>
<name><surname>S&#xE1;ez</surname><given-names>D.</given-names></name>
<name><surname>&#xC1;lvarez</surname><given-names>F.</given-names></name>
<name><surname>Molina</surname><given-names>R.</given-names></name>
<name><surname>Flores</surname><given-names>M.</given-names></name>
<name><surname>O&#xF1;ate</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Multivalent Fusion DNA Vaccine against <italic toggle="yes">Brucella abortus</italic></article-title>
          <source>BioMed Res. Int.</source>
          <year>2017</year>
          <volume>2017</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1155/2017/6535479</pub-id>
          <pub-id pub-id-type="pmid">29082252</pub-id>
        </element-citation>
      </ref>
      <ref id="B177-vaccines-11-00654">
        <label>177.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gheibi</surname><given-names>A.</given-names></name>
<name><surname>Khanahmad</surname><given-names>H.</given-names></name>
<name><surname>Kashfi</surname><given-names>K.</given-names></name>
<name><surname>Sarmadi</surname><given-names>M.</given-names></name>
<name><surname>Khorramizadeh</surname><given-names>M.R.</given-names></name>
</person-group>
          <article-title>Development of new generation of vaccines for <italic toggle="yes">Brucella abortus</italic></article-title>
          <source>Heliyon</source>
          <year>2018</year>
          <volume>4</volume>
          <fpage>e01079</fpage>
          <pub-id pub-id-type="doi">10.1016/j.heliyon.2018.e01079</pub-id>
          <pub-id pub-id-type="pmid">30603712</pub-id>
        </element-citation>
      </ref>
      <ref id="B178-vaccines-11-00654">
        <label>178.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gurunathan</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>C.-Y.</given-names></name>
<name><surname>Freidag</surname><given-names>B.L.</given-names></name>
<name><surname>A Seder</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>DNA vaccines: A key for inducing long-term cellular immunity</article-title>
          <source>Curr. Opin. Immunol.</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>442</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="doi">10.1016/S0952-7915(00)00118-7</pub-id>
          <pub-id pub-id-type="pmid">10899026</pub-id>
        </element-citation>
      </ref>
      <ref id="B179-vaccines-11-00654">
        <label>179.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ingolotti</surname><given-names>M.</given-names></name>
<name><surname>Kawalekar</surname><given-names>O.</given-names></name>
<name><surname>Shedlock</surname><given-names>D.J.</given-names></name>
<name><surname>Muthumani</surname><given-names>K.</given-names></name>
<name><surname>Weiner</surname><given-names>D.B.</given-names></name>
</person-group>
          <article-title>DNA vaccines for targeting bacterial infections</article-title>
          <source>Expert Rev. Vaccines</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>747</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="doi">10.1586/erv.10.57</pub-id>
          <pub-id pub-id-type="pmid">20624048</pub-id>
        </element-citation>
      </ref>
      <ref id="B180-vaccines-11-00654">
        <label>180.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ko</surname><given-names>J.</given-names></name>
<name><surname>Splitter</surname><given-names>G.A.</given-names></name>
</person-group>
          <article-title>Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans</article-title>
          <source>Clin. Microbiol. Rev.</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>65</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1128/CMR.16.1.65-78.2003</pub-id>
          <pub-id pub-id-type="pmid">12525425</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig position="float" id="vaccines-11-00654-f001">
      <label>Figure 1</label>
      <caption>
        <p>A diagnostic algorithm for zoonotic brucellosis that is based on laboratory findings.</p>
      </caption>
      <graphic xlink:href="vaccines-11-00654-g001" position="float"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>